<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:34:51Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7674973" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7674973</identifier>
        <datestamp>2020-11-24</datestamp>
        <setSpec>molsystbiol</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Mol Syst Biol</journal-id>
              <journal-id journal-id-type="iso-abbrev">Mol Syst Biol</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1744-4292</journal-id>
              <journal-id journal-id-type="publisher-id">MSB</journal-id>
              <journal-id journal-id-type="hwp">msb</journal-id>
              <journal-title-group>
                <journal-title>Molecular Systems Biology</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1744-4292</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7674973</article-id>
              <article-id pub-id-type="pmcid">PMC7674973</article-id>
              <article-id pub-id-type="pmc-uid">7674973</article-id>
              <article-id pub-id-type="pmid">33210468</article-id>
              <article-id pub-id-type="doi">10.15252/msb.20209888</article-id>
              <article-id pub-id-type="publisher-id">MSB20209888</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine</article-title>
                <alt-title alt-title-type="left-running-head">Daniel O'Connor <italic>et al</italic></alt-title>
              </title-group>
              <contrib-group>
                <contrib id="msb20209888-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>O’Connor</surname>
                    <given-names>Daniel</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6902-9886</contrib-id>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <address>
                    <email>daniel.oconnor@paediatrics.ox.ac.uk</email>
                  </address>
                </contrib>
                <contrib id="msb20209888-cr-0002" contrib-type="author">
                  <name>
                    <surname>Pinto</surname>
                    <given-names>Marta Valente</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0003" contrib-type="author">
                  <name>
                    <surname>Sheerin</surname>
                    <given-names>Dylan</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9456-5712</contrib-id>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0004" contrib-type="author">
                  <name>
                    <surname>Tomic</surname>
                    <given-names>Adriana</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0005" contrib-type="author">
                  <name>
                    <surname>Drury</surname>
                    <given-names>Ruth E</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0006" contrib-type="author">
                  <name>
                    <surname>Channon‐Wells</surname>
                    <given-names>Samuel</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8166-8680</contrib-id>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0007" contrib-type="author">
                  <name>
                    <surname>Galal</surname>
                    <given-names>Ushma</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0008" contrib-type="author">
                  <name>
                    <surname>Dold</surname>
                    <given-names>Christina</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0009" contrib-type="author">
                  <name>
                    <surname>Robinson</surname>
                    <given-names>Hannah</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0010" contrib-type="author">
                  <name>
                    <surname>Kerridge</surname>
                    <given-names>Simon</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0011" contrib-type="author">
                  <name>
                    <surname>Plested</surname>
                    <given-names>Emma</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0012" contrib-type="author">
                  <name>
                    <surname>Hughes</surname>
                    <given-names>Harri</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0013" contrib-type="author">
                  <name>
                    <surname>Stockdale</surname>
                    <given-names>Lisa</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0014" contrib-type="author">
                  <name>
                    <surname>Sadarangani</surname>
                    <given-names>Manish</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0015" contrib-type="author">
                  <name>
                    <surname>Snape</surname>
                    <given-names>Matthew D</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0016" contrib-type="author">
                  <name>
                    <surname>Rollier</surname>
                    <given-names>Christine S</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9712-8080</contrib-id>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0017" contrib-type="author">
                  <name>
                    <surname>Levin</surname>
                    <given-names>Michael</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="msb20209888-cr-0018" contrib-type="author">
                  <name>
                    <surname>Pollard</surname>
                    <given-names>Andrew J</given-names>
                  </name>
                  <xref ref-type="aff" rid="msb20209888-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="msb20209888-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="msb20209888-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Paediatrics</named-content>
                <institution>University of Oxford</institution>
                <city>Oxford</city>
                <country country="GB">UK</country>
              </aff>
              <aff id="msb20209888-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">NIHR Oxford Biomedical Research Centre</named-content>
                <institution>Oxford University Hospitals NHS Foundation Trust</institution>
                <city>Oxford</city>
                <country country="GB">UK</country>
              </aff>
              <aff id="msb20209888-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Institute of Immunity, Transplantation and Infection</named-content>
                <institution>Stanford University School of Medicine</institution>
                <city>Stanford</city>
                <named-content content-type="country-part">CA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="msb20209888-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Nuffield Department of Primary Health Care</named-content>
                <named-content content-type="organisation-division">Clinical Trials Unit</named-content>
                <institution>University of Oxford</institution>
                <city>Oxford</city>
                <country country="GB">UK</country>
              </aff>
              <aff id="msb20209888-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Pediatrics</named-content>
                <institution>University of British Columbia</institution>
                <city>Vancouver</city>
                <country country="CA">Canada</country>
              </aff>
              <aff id="msb20209888-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Division of Infectious Diseases</named-content>
                <named-content content-type="organisation-division">Department of Medicine</named-content>
                <institution>Imperial College London</institution>
                <city>London</city>
                <country country="GB">UK</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>
Corresponding author. Tel: +44 1865611365; E‐mail: <email>daniel.oconnor@paediatrics.ox.ac.uk</email><break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>19</day>
                <month>11</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>11</month>
                <year>2020</year>
              </pub-date>
              <volume>16</volume>
              <issue>11</issue>
              <issue-id pub-id-type="doi">10.1002/msb.v16.11</issue-id>
              <elocation-id>e9888</elocation-id>
              <history>
                <date date-type="received">
                  <day>26</day>
                  <month>7</month>
                  <year>2020</year>
                </date>
                <date date-type="rev-recd">
                  <day>06</day>
                  <month>10</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>08</day>
                  <month>10</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 EMBO <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2020 The Authors. Published under the terms of the CC BY 4.0 license.</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:MSB-16-e9888.pdf"/>
              <abstract id="msb20209888-abs-0001">
                <title>Abstract</title>
                <p><italic>Neisseria meningitidis</italic> is a major cause of meningitis and septicaemia. A MenB vaccine (4CMenB) was licensed by the European Medicines Agency in January 2013. Here we describe the blood transcriptome and proteome following infant immunisations with or without concomitant 4CMenB, to gain insight into the molecular mechanisms underlying post‐vaccination reactogenicity and immunogenicity. Infants were randomised to receive control immunisations (PCV13 and DTaP‐IPV‐Hib) with or without 4CMenB at 2 and 4 months of age. Blood gene expression and plasma proteins were measured prior to, then 4 h, 24 h, 3 days or 7 days post‐vaccination. 4CMenB vaccination was associated with increased expression of <italic>ENTPD7</italic> and increased concentrations of 4 plasma proteins: CRP, G‐CSF, IL‐1RA and IL‐6. Post‐vaccination fever was associated with increased expression of <italic>SELL</italic>, involved in neutrophil recruitment. A murine model dissecting the vaccine components found the concomitant regimen to be associated with increased gene perturbation compared with 4CMenB vaccine alone with enhancement of pathways such as interleukin‐3, ‐5 and GM‐CSF signalling. Finally, we present transcriptomic profiles predictive of immunological and febrile responses following 4CMenB vaccine.</p>
              </abstract>
              <abstract abstract-type="graphical" id="msb20209888-abs-0003">
                <p>A randomised clinical trial evaluates transcriptomic and proteomic profiles following infant concomitant 4CMenB vaccination, compared with control vaccines alone. A novel framework is provided for both understanding and predicting vaccine immunogenicity and reactogenicity.<boxed-text position="anchor" content-type="graphic" id="msb20209888-blkfxd-0002" orientation="portrait"><graphic xlink:href="MSB-16-e9888-g010.jpg" position="anchor" id="nlm-graphic-3" orientation="portrait"/></boxed-text>
</p>
              </abstract>
              <kwd-group>
                <kwd id="msb20209888-kwd-0001">paediatrics</kwd>
                <kwd id="msb20209888-kwd-0002">proteomics</kwd>
                <kwd id="msb20209888-kwd-0003">systems biology</kwd>
                <kwd id="msb20209888-kwd-0004">transcriptomics</kwd>
                <kwd id="msb20209888-kwd-0005">vaccines</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Immunology</kwd>
                <kwd>Microbiology, Virology &amp; Host Pathogen Interaction</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>FP7 Ideas: European Research Council (FP7 Ideas) </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100011199</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>279185</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>UKRI | Medical Research Council (MRC) </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/501100000265</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>GlaxoSmithKline Biologicals S.A</funding-source>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIHR | NIHR Oxford Biomedical Research Centre (OxBRC) </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/501100013373</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="10"/>
                <table-count count="1"/>
                <page-count count="19"/>
                <word-count count="28573"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>November 2020</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.4 mode:remove_FC converted:19.11.2020</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="msb20209888-cit-1001"><source xml:lang="en">Mol Syst Biol</source>. (<year>2020</year>) <volume>16</volume>: <elocation-id>e9888</elocation-id></mixed-citation>
              </p>
            </notes>
          </front>
          <body id="msb20209888-body-0001">
            <sec id="msb20209888-sec-0001">
              <title>Introduction</title>
              <p><italic>Neisseria meningitidis</italic> is estimated to cause 0.5–1.2 million infections and 50,000–135,000 deaths worldwide each year (Stephens <italic>et al</italic>, <xref rid="msb20209888-bib-0081" ref-type="ref">2007</xref>; Rouphael &amp; Stephens, <xref rid="msb20209888-bib-0071" ref-type="ref">2012</xref>). Clinical outcomes of invasive infection vary by setting and strain, but even in resource‐rich countries, permanent neurological sequelae are common in survivors and 5–10% of those affected die (Wilder‐Smith &amp; Memish, <xref rid="msb20209888-bib-0098" ref-type="ref">2003</xref>). While susceptibility to invasive meningococcal disease is not completely understood, an inverse relationship is seen with the prevalence of complement‐dependent serum bactericidal antibody (SBA) titres and the incidence of meningococcal meningitis (Goldschneider <italic>et al</italic>, <xref rid="msb20209888-bib-0027" ref-type="ref">1969</xref>). Moreover, the levels of SBA correlate with post‐immunisation protection from meningococcal disease at the population level (Andrews <italic>et al</italic>, <xref rid="msb20209888-bib-0001" ref-type="ref">2003</xref>).</p>
              <p>Capsular group B organisms cause most invasive meningococcal disease in developed countries (Pollard, <xref rid="msb20209888-bib-0062" ref-type="ref">2004</xref>). In 2013, a multicomponent group B meningococcal vaccine (4CMenB, Bexsero, GSK), containing outer membrane vesicles from a meningococcal strain (NZ98/254) and three recombinant proteins, was licensed (Rollier <italic>et al</italic>, <xref rid="msb20209888-bib-0070" ref-type="ref">2015</xref>). Subsequently, 12 European countries, as well as Canada, Australia and some Latin American countries, have issued recommendations related to its use in infancy (ECDC, <xref rid="msb20209888-bib-0019" ref-type="ref">2017</xref>). In late 2015, the UK introduced this vaccine into a national, infant immunisation programme. A two‐dose primary schedule of 4CMenB has been shown to be highly effective in preventing group B infection in infants (Parikh <italic>et al</italic>, <xref rid="msb20209888-bib-0059" ref-type="ref">2016</xref>). However, when given concomitantly with other routine infant immunisations, fever (≥ 38°C) is a common adverse reaction (&gt; 60%) (Gossger <italic>et al</italic>, <xref rid="msb20209888-bib-0029" ref-type="ref">2012</xref>; Martinón‐Torres <italic>et al</italic>, <xref rid="msb20209888-bib-0049" ref-type="ref">2017</xref>). While post‐vaccination fever is generally a mild and benign event, it can concern parents and healthcare professionals and is indistinguishable from coincidental intercurrent infection, resulting in unnecessary medical visits, invasive procedures and laboratory investigations, which have an associated healthcare burden (Kapur <italic>et al</italic>, <xref rid="msb20209888-bib-0038" ref-type="ref">2017</xref>; Nainani <italic>et al</italic>, <xref rid="msb20209888-bib-0052" ref-type="ref">2017</xref>). Prophylactic paracetamol (acetaminophen) has been shown to reduce fever rates post‐vaccination (Prymula <italic>et al</italic>, <xref rid="msb20209888-bib-0064" ref-type="ref">2014</xref>). Therefore, various public health agencies (including Public Health England) have advised the use of prophylactic paracetamol for primary immunisations (at 2 and 4 months of age), when this vaccine was introduced into their respective infant immunisation programmes. Despite this recommendation, to which there appears good compliance (~ 94%), data from the United Kingdom have shown an increase in hospital attendances (estimated 1,440 additional visits per year) with transient adverse events following immunisation (AEFIs) since the introduction of the 4CMenB vaccine (Kapur <italic>et al</italic>, <xref rid="msb20209888-bib-0038" ref-type="ref">2017</xref>; Murdoch <italic>et al</italic>, <xref rid="msb20209888-bib-0051" ref-type="ref">2017</xref>; Nainani <italic>et al</italic>, <xref rid="msb20209888-bib-0052" ref-type="ref">2017</xref>). Current clinical guidance for managing febrile infants is justifiably cautious, as it is often difficult to distinguish benign causes of fever (such as viral infections or vaccination) from the small proportion who have life‐threatening bacterial infections (Craig <italic>et al</italic>, <xref rid="msb20209888-bib-0014" ref-type="ref">2010</xref>; Esposito <italic>et al</italic>, <xref rid="msb20209888-bib-0020" ref-type="ref">2014</xref>; Irwin <italic>et al</italic>, <xref rid="msb20209888-bib-0035" ref-type="ref">2017</xref>). Consequently, post‐vaccination hospital admissions are resulting in additional and unnecessary laboratory tests, invasive procedures (e.g. lumbar punctures) and/or antibiotic usage (Kapur <italic>et al</italic>, <xref rid="msb20209888-bib-0038" ref-type="ref">2017</xref>). These are important factors when considering the implications associated with vaccine reactogenicity. Moreover, unfavourable vaccine reactogenicity may impact uptake of the specific vaccine or vaccines in general, with important implications. There is a need to understand both vaccine and vaccinee factors underlying vaccine reactogenicity, not least because this will guide the development of a new generation of vaccines with optimal reactogenicity profiles while preserving (or enhancing) immunogenicity. Recent reports have shown the power of peripheral blood RNA signatures in discerning the aetiology of acute febrile illness in children (Kaforou <italic>et al</italic>, <xref rid="msb20209888-bib-0037" ref-type="ref">2013</xref>; Anderson <italic>et al</italic>, <xref rid="msb20209888-bib-0003" ref-type="ref">2014</xref>; Herberg <italic>et al</italic>, <xref rid="msb20209888-bib-0034" ref-type="ref">2016</xref>; Mahajan <italic>et al</italic>, <xref rid="msb20209888-bib-0047" ref-type="ref">2016</xref>; Wright <italic>et al</italic>, <xref rid="msb20209888-bib-0099" ref-type="ref">2018</xref>). Moreover, studies have also shown the fitness of such approaches in elucidating the molecular mechanisms underlying, and even predicting, immune responses, both in the context of vaccination and infectious challenge (Tsang <italic>et al</italic>, <xref rid="msb20209888-bib-0085" ref-type="ref">2014</xref>; Blohmke <italic>et al</italic>, <xref rid="msb20209888-bib-0006" ref-type="ref">2016</xref>; Davenport <italic>et al</italic>, <xref rid="msb20209888-bib-0015" ref-type="ref">2016</xref>; Hemingway <italic>et al</italic>, <xref rid="msb20209888-bib-0032" ref-type="ref">2017</xref>; von Both <italic>et al</italic>, <xref rid="msb20209888-bib-0092" ref-type="ref">2018</xref>). Here we leveraged contemporary transcriptomic and proteomic approaches to dissect the mechanisms involved in both the reactogenicity and immunogenicity following infant immunisation. We then recapitulated these finding in a mouse model, further exploring the specific vaccine components underlying the early blood transcriptome following 4CMenB vaccination.</p>
            </sec>
            <sec sec-type="results" id="msb20209888-sec-0002">
              <title>Results</title>
              <sec id="msb20209888-sec-0003">
                <title>Fever is more commonly observed in 4CMenB‐vaccinated infants</title>
                <p>One hundred and eighty‐one (92 test and 89 control group) infants completed this study (Fig <xref rid="msb20209888-fig-0001" ref-type="fig">1</xref>, Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S1</xref> and Dataset <xref rid="msb20209888-sup-0003" ref-type="supplementary-material">EV2</xref>). All infants had a baseline blood sample; and 28, 31, 30 and 36 infants had a blood sample at 4 h, 24 h, 3 days and 7 days, respectively. After 4CMenB plus control vaccination, the proportion of infants with at least one temperature recording ≥ 38°C within 24 h of receiving their 4‐month dose of study vaccines was higher (59.6% [95% CI: 48.6, 69.8]) than in infants who received the control vaccines alone (27.3% [95% CI: 18.3, 37.8]; Dataset <xref rid="msb20209888-sup-0004" ref-type="supplementary-material">EV3</xref>). Likewise, a statistically significant difference was observed in the Kaplan–Meier curves of time‐to‐fever event between the two vaccine study arms (log‐rank test, <italic>P</italic> &lt; 0.001; Fig <xref rid="msb20209888-fig-0002" ref-type="fig">2A</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Study overview</p>
                  </caption>
                  <graphic id="nlm-graphic-5" xlink:href="MSB-16-e9888-g002"/>
                </fig>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0002" orientation="portrait" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <title>Fever incidence within 24 h of study vaccines</title>
                    <p>
                      <list list-type="alpha-upper" id="msb20209888-list-0002">
                        <list-item>
                          <p>Kaplan‐Meier to first fever (≥ 38°C) episode within 24 h of receiving vaccines administered at 4 months of age; control <italic>n</italic> = 88 and 4CMenB <italic>n</italic> = 89.</p>
                        </list-item>
                        <list-item>
                          <p>Principal component (PC) analysis of RNA‐sequencing data (14,837 genes, <italic>n</italic> = 253) from all study time points. The lines connect participant's pre‐ and post‐vaccination samples. The ellipses are the two‐dimensional (PC1 and PC2) 95% confidence intervals for each study time point. A contribution plot (top right) displays the genes contributing most to PC1/PC2, i.e. 0.15 implies 0.15% contribution of that variable to the principal components displayed.</p>
                        </list-item>
                        <list-item>
                          <p>Plotted are the CIBERSORTx neutrophil fractions from whole blood RNA‐sequencing data, with median and interquartile range. <italic>P</italic>‐values were determined from a two‐sample Wilcoxon rank sum test. The number of individuals in each group is display in the <italic>x</italic>‐axis.</p>
                        </list-item>
                        <list-item>
                          <p>Spearman's rank correlation between neutrophil counts measure by full blood counts (<italic>n</italic> = 142) and those estimated by CIBERSORTx, using the LM22 signature matrix.</p>
                        </list-item>
                      </list>
                    </p>
                  </caption>
                  <graphic id="nlm-graphic-7" xlink:href="MSB-16-e9888-g003"/>
                </fig>
              </sec>
              <sec id="msb20209888-sec-0004">
                <title>Increase in neutrophils post‐vaccination is associated with global blood transcriptional perturbation</title>
                <p>Principal component (PC) analysis of blood transcriptome RNA‐sequencing data from all study time points showed clustering of early (&lt; 24 h) post‐vaccination samples on the first and second PCs (Fig <xref rid="msb20209888-fig-0002" ref-type="fig">2B</xref>). Analysis of the genes with the greatest contribution to this clustering revealed that <italic>CD177</italic>, a neutrophil‐specific gene involved in neutrophil activation, was the leading contributor to (i.e. correlate with) PC 2 (Fig <xref rid="msb20209888-fig-0002" ref-type="fig">2B</xref>). Full blood count (FBC) analysis showed neutrophil counts increased 4 h after vaccination (both test and control group), peaking at 24 h, before returning to baseline by 3 days (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S2</xref>). The neutrophil fraction determined from the transcriptome data (CIBERSORT) mirrored neutrophil counts in the FBC, and the two measures were highly correlated (rho = 0.81, <italic>P</italic> &lt; 2.2 × 10<sup>−16</sup>; Fig <xref rid="msb20209888-fig-0002" ref-type="fig">2C and D</xref> and Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S2</xref>). PC analysis of CIBERSORT cell fraction data showed clustering of early post‐vaccination samples, and the most important contributor to this clustering (PC1) was the neutrophil count (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S3</xref>). These analyses reveal that an increase in neutrophils early post‐vaccination is associated with comprehensive changes to the underlying structure to the blood transcriptome (Fig <xref rid="msb20209888-fig-0002" ref-type="fig">2B</xref>).</p>
              </sec>
              <sec id="msb20209888-sec-0005">
                <title>Peak in blood transcriptome differential gene expression 24 h after infant vaccination</title>
                <p>In this study, the greatest number of differentially expressed genes (DEGs, FDR &lt; 0.01) compared with baseline (pre‐vaccination at 4 months), when the two vaccine groups (test and control) were combined, was seen 24 h post‐vaccination (DEGs = 5,553; Fig <xref rid="msb20209888-fig-0003" ref-type="fig">3</xref>). It was noted that more upregulated genes surpassed the threshold for differential expression than downregulated genes (Fig <xref rid="msb20209888-fig-0003" ref-type="fig">3A–D</xref>). However, this asymmetry was attenuated when transcriptomic data were corrected for neutrophil cell abundance (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S4</xref>). Of note, adjusting for neutrophil abundance reduced the number of DEGs at 4 h (719 vs. 161 DEGs) and 24 h (5,553 vs. 3,228 DEGs) post‐vaccination (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S4</xref>). DEGs were also observed at the later time points, although fewer than at the early time points, 3 days (DEGs = 159) and 7 days (DEGs = 6; Fig <xref rid="msb20209888-fig-0003" ref-type="fig">3C and D</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0003" orientation="portrait" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <title>Blood gene signatures following infant vaccination</title>
                    <p>
                      <list list-type="alpha-upper" id="msb20209888-list-0003">
                        <list-item>
                          <p>Volcano plot highlighting differentially expressed genes (DEGs, false discovery rate [FDR] &lt; 0.01; red upregulated and blue downregulated) at each study time point versus pre‐vaccination (4 months of age) 4 h post‐vaccination (719 DEGs, <italic>n</italic> = 28). <italic>P</italic>‐values were obtained from the moderated t‐statistic, after adjustment for multiple testing (Benjamini and Hochberg's method). The top 10 genes, ranked by FDR, are labelled.</p>
                        </list-item>
                        <list-item>
                          <p>Same as (A) but 24 h post‐vaccination (5,553 DEGs, <italic>n</italic> = 31).</p>
                        </list-item>
                        <list-item>
                          <p>Same as (A) but 3 days post‐vaccination (159 DEGs, <italic>n</italic> = 30).</p>
                        </list-item>
                        <list-item>
                          <p>Same as (A) but 7 days post‐vaccination (6 DEGs, <italic>n</italic> = 36).</p>
                        </list-item>
                        <list-item>
                          <p>Modular signature induced following infant vaccination. Enriched modules (FDR &lt; 0.001) are displayed. Segments of the pie charts represent the proportion of upregulated (red) and downregulated (blue) genes (absolute fold change &gt; 1.25). Enrichment <italic>P</italic>‐values were derived from a hypergeometric test, after adjustment for multiple testing (Benjamini and Hochberg's method).</p>
                        </list-item>
                      </list>
                    </p>
                  </caption>
                  <graphic id="nlm-graphic-9" xlink:href="MSB-16-e9888-g004"/>
                </fig>
              </sec>
              <sec id="msb20209888-sec-0006">
                <title>Early gene regulation is generally consistent between vaccine groups</title>
                <p>We next investigated whether gene regulation differed between infants who received the control vaccines only compared with those who received the additional test vaccine (4CMenB). Moreover, when all DEGs in either study vaccine regimen were considered, they generally showed similar regulation (i.e. same directionality; Appendix Figs <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S5 and S6</xref>). Correspondingly, blood transcriptional module analysis of the early study time points showed both the test and control groups upregulated genes associated with neutrophils and monocytes (Fig <xref rid="msb20209888-fig-0003" ref-type="fig">3E</xref>). The immune activation module remained enriched until 3 days post‐vaccination, albeit with a smaller effect size than at 4‐ and 24‐h time points (Fig <xref rid="msb20209888-fig-0003" ref-type="fig">3E</xref>). At 7 days post‐vaccination, DEGs were enriched for genes associated with the plasma cells gene module (Fig <xref rid="msb20209888-fig-0003" ref-type="fig">3E</xref>). This similarity in early transcriptional signatures between the vaccine groups was also illustrated in gene ontology analysis (Appendix Figs <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S7–S9</xref>).</p>
              </sec>
              <sec id="msb20209888-sec-0007">
                <title>Divergent transcriptomic and proteomic signatures in infants who received 4CMenB</title>
                <p>While most transcriptional regulation was similar in both the study vaccine arms, three genes (<italic>ENTPD7</italic> [24 h], <italic>IGHG3</italic> [day 7] and <italic>IGLV9‐49</italic> [day 7]) were significantly differentially regulated (FDR &lt; 0.05) in infants who received 4CMenB compared with those who received the control vaccines alone (Fig <xref rid="msb20209888-fig-0004" ref-type="fig">4A–D</xref>, Datasets <xref rid="msb20209888-sup-0005" ref-type="supplementary-material">[Link]</xref>, <xref rid="msb20209888-sup-0006" ref-type="supplementary-material">[Link]</xref>, <xref rid="msb20209888-sup-0007" ref-type="supplementary-material">[Link]</xref>, <xref rid="msb20209888-sup-0008" ref-type="supplementary-material">[Link]</xref>). The time course expression profiles of the top genes (ranked by <italic>P</italic>‐value) differing between vaccine treatments are displayed in Fig <xref rid="msb20209888-fig-0004" ref-type="fig">4</xref>.</p>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0004" orientation="portrait" position="float">
                  <label>Figure 4</label>
                  <caption>
                    <title>Differential gene regulation between vaccine groups</title>
                    <p>
                      <list list-type="alpha-upper" id="msb20209888-list-0004">
                        <list-item>
                          <p>Top genes differentially regulated between vaccine groups 4 h post‐vaccination. Note, only genes differentially expressed in either study group (concomitant 4CMenB or control vaccines alone) were included in intergroup analysis. The plotted lines are the LOESS (locally estimated scatterplot smoothing) regression curves with the 95% confidence intervals in grey. The FDR was derived by comparing fold changes in gene expression in the control group with the test group, from baseline to the time point designated, and is reported if statistically significant (FDR &lt; 0.05). <italic>P</italic>‐values were obtained from the moderated t‐statistic, after adjustment for multiple testing (Benjamini and Hochberg's method). Pre‐vaccination samples <italic>n</italic> = 125, 4 h samples <italic>n</italic> = 28, 24 h samples <italic>n</italic> = 31, 3 day sample <italic>n</italic> = 30, 7 day samples <italic>n</italic> = 36. The expression E value is the gene expression value derived from the voom‐limma workflow (Law <italic>et al</italic>, <xref rid="msb20209888-bib-0044" ref-type="ref">2014</xref>).</p>
                        </list-item>
                        <list-item>
                          <p>Same as (A) but top genes differentially regulated between vaccine groups 24 h post‐vaccination.</p>
                        </list-item>
                        <list-item>
                          <p>Same as (A) but top genes differentially regulated between vaccine groups 3 days post‐vaccination.</p>
                        </list-item>
                        <list-item>
                          <p>Same as (A) but top genes differentially regulated between vaccine groups 7 days post‐vaccination.</p>
                        </list-item>
                      </list>
                    </p>
                  </caption>
                  <graphic id="nlm-graphic-11" xlink:href="MSB-16-e9888-g005"/>
                </fig>
                <p>A panel of 25 plasma proteins concentration was evaluated prior to vaccination and then at 4 and 24 h after vaccination. The concentration of five of these plasma proteins to changed (FDR &lt; 0.05) at 24 h post‐vaccination (Dataset <xref rid="msb20209888-sup-0009" ref-type="supplementary-material">EV8</xref>). Moreover, the concentrations of four of these protein—CRP, G‐CSF, IL‐1RA and IL‐6—were higher (FDR &lt; 0.05) in the test group compared with the control vaccine group, 24 h post‐vaccination (Fig <xref rid="msb20209888-fig-0005" ref-type="fig">5</xref>). These plasma cytokines were also highly correlated with the neutrophil fraction, as determined from the transcriptome data (CIBERSORTx; Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S10</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0005" orientation="portrait" position="float">
                  <label>Figure 5</label>
                  <caption>
                    <title>Plasma proteins that differed in concentrations following vaccination in the test compare with the control vaccine group</title>
                    <p>False discovery rate (FDR) is displayed above and were derived from a two‐sample Wilcoxon rank sum test (Benjamini–Hochberg correction). Vertical lines represent the interquartile range around the median. The red dashed horizontal line is upper limit of the normal CRP reference interval (0–5 mg/l). The number of individuals in each group is display in the <italic>x</italic>‐axis.</p>
                  </caption>
                  <graphic id="nlm-graphic-13" xlink:href="MSB-16-e9888-g006"/>
                </fig>
              </sec>
              <sec id="msb20209888-sec-0008">
                <title>Identification of early gene signature associated with fever following infant vaccination</title>
                <p>We next explored whether there were transcriptional differences between infants who experienced a fever within 24 h of vaccination and those who remained afebrile, irrespective of the which vaccines they received. We found gene regulation to be generally consistent between these subcategories of infants (Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6A and B</xref>). However, a single gene (<italic>SELL</italic>) was statistically significantly differentially regulated (FDR &lt; 0.05) between febrile and afebrile infants, 4 h post‐vaccination (Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6C</xref> and Dataset <xref rid="msb20209888-sup-0010" ref-type="supplementary-material">EV9</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0006" orientation="portrait" position="float">
                  <label>Figure 6</label>
                  <caption>
                    <title>Comparison of blood gene profiles of infants who experienced post‐vaccination fever with those who remained afebrile</title>
                    <p>
                      <list list-type="simple" id="msb20209888-list-0005">
                        <list-item>
                          <label>A, B</label>
                          <p>Agreement plot. Red = differentially expressed (DE) in febrile infants, blue = DE in afebrile infants, purple = DE in febrile and afebrile infants.</p>
                        </list-item>
                        <list-item>
                          <label>C</label>
                          <p>Exemplar genes differentially expressed at 4 and 24 h, respectively, between infants who experienced a fever within 24 h of vaccination and afebrile infants. The plotted lines are the LOESS (locally estimated scatterplot smoothing) regression curves with the 95% confidence intervals in grey. The false discovery rate (FDR) was derived by comparing fold changes in gene expression between infants who experienced post‐vaccination fever and those who remained afebrile. <italic>P</italic>‐values were obtained from the moderated t‐statistic, after adjustment for multiple testing (Benjamini and Hochberg's method). Pre‐vaccination samples <italic>n</italic> = 125, 4 h samples <italic>n</italic> = 28, 24 h samples <italic>n</italic> = 31, 3 day sample <italic>n</italic> = 30, 7 day samples <italic>n</italic> = 36.</p>
                        </list-item>
                        <list-item>
                          <label>D</label>
                          <p>Performance of predictive model built with sparse distance weighted discrimination (sdwd) algorithm to predict fever following concomitant 4CMenB vaccine.</p>
                        </list-item>
                        <list-item>
                          <label>E</label>
                          <p>Variable importance score of the features from the sdwd model.</p>
                        </list-item>
                        <list-item>
                          <label>F</label>
                          <p>Expression levels (Limma E value) of the top three transcripts from the sdwd model in the individuals that develop fever (<italic>n</italic> = 33, red circles) and those that don't develop fever (<italic>n</italic> = 21, blue circles).</p>
                        </list-item>
                        <list-item>
                          <label>G–I</label>
                          <p>Support vector regression (SVR) performance of model to predict post‐vaccination MenB‐specific SBA titres, (G) training dataset (<italic>n</italic> = 36), (H) performance of model in the test dataset (<italic>n</italic> = 9), I) the top five genes ranked by importance from the SVR model.</p>
                        </list-item>
                      </list>
                    </p>
                  </caption>
                  <graphic id="nlm-graphic-15" xlink:href="MSB-16-e9888-g007"/>
                </fig>
              </sec>
              <sec id="msb20209888-sec-0009">
                <title>Baseline gene profiles predictive of immune response and reactogenicity</title>
                <p>To explore the ability of baseline transcriptome data to predict subsequent vaccine‐induced reactogenicity, we used a recently described approach that optimises a machine learning workflow through a Sequential Iterative Modelling “OverNight” (SIMON) (preprint: Tomic <italic>et al</italic>, <xref rid="msb20209888-bib-0084" ref-type="ref">2019</xref>). SIMON, an automated machine learning approach, compares results from more than 100 different algorithms (preprint: Tomic <italic>et al</italic>, <xref rid="msb20209888-bib-0084" ref-type="ref">2019</xref>). Here, we applied SIMON to baseline data before vaccination obtained from 54 infants that received 4CMenB vaccine in the test group. The outcome was determined as “fever” if the temperature recording was ≥ 38°C in the first 24 h post‐vaccination. Since the number of genes is far greater than the number of donors, to avoid “curse of dimensionality”, i.e. poor predictive power (Bellman, <xref rid="msb20209888-bib-0004" ref-type="ref">1957</xref>), we performed feature selection before starting the SIMON analysis. The feature selection process facilitates the building a highly accurate models by focusing on the most important and relevant features (Bommert <italic>et al</italic>, <xref rid="msb20209888-bib-0007" ref-type="ref">2020</xref>). To identify the most important features we utilised two different approaches, (i) using DEGs in either febrile or afebrile infants at the two early study time points (i.e. 4‐ and 24‐h post‐vaccination) or (ii) PCA analysis, as reported previously (Golub <italic>et al</italic>, <xref rid="msb20209888-bib-0028" ref-type="ref">1999</xref>; Song <italic>et al</italic>, <xref rid="msb20209888-bib-0078" ref-type="ref">2010</xref>). In total, five different datasets were generated (as described in Methods) for SIMON analysis. Models built with SIMON on the datasets generated using DEGs had a maximum AUROC of 0.68 and 0.75, for DEGs at the 4‐ and 24‐h time points, respectively (Datasets <xref rid="msb20209888-sup-0011" ref-type="supplementary-material">EV10</xref> and <xref rid="msb20209888-sup-0012" ref-type="supplementary-material">EV11</xref>). Automated model selection algorithms perform well on the features selected using the PCA, as previously described (Kohavi &amp; John, <xref rid="msb20209888-bib-0042" ref-type="ref">1997</xref>). We performed SIMON analysis on datasets containing the top 500, 200 and 100 transcripts contributing to PC1 (Datasets <xref rid="msb20209888-sup-0014" ref-type="supplementary-material">[Link]</xref>, <xref rid="msb20209888-sup-0015" ref-type="supplementary-material">[Link]</xref>, <xref rid="msb20209888-sup-0016" ref-type="supplementary-material">[Link]</xref>). The top performing models were selected using the dataset containing 200 genes from the PC1 (39.8% variance explained by the PC1; Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S12</xref>A and Dataset <xref rid="msb20209888-sup-0013" ref-type="supplementary-material">EV12</xref>).</p>
                <p>Out of 215 machine learning algorithms evaluated, SIMON successfully built seven models with good discriminative ability calculated as area under ROC (AUROC) &gt; 0.7 on both training and withheld test set (Dataset <xref rid="msb20209888-sup-0014" ref-type="supplementary-material">EV13</xref>). The model with the highest performance measurements was built using a sparse distance weighted discrimination algorithm (Wang &amp; Zou, <xref rid="msb20209888-bib-0095" ref-type="ref">2016</xref>) with train AUROC of 0.7867 and test AUROC of 0.7 (Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6D</xref> and Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S12</xref>B). Of the total 200 genes, three genes, APBA3, AASS and FKBP4, were able to discriminate between infants that developed fever and those who remained afebrile (Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6E</xref> and Dataset <xref rid="msb20209888-sup-0017" ref-type="supplementary-material">EV16</xref>). APBA3 had the highest contribution with variable importance score 100 in three other models also built with good predictive measurements (Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6D and E</xref>). Moreover, lower performance was observed (train AUROC 0.6) with the removal of <italic>APBA3</italic>, as evaluated using the dataset that contained only 100 transcripts from the PC1 (i.e. no <italic>APBA3</italic> included; Dataset <xref rid="msb20209888-sup-0015" ref-type="supplementary-material">EV14</xref>). Infants that developed fever after 4CMenB vaccine had lower expression levels of <italic>APBA3</italic> and <italic>FKBP4</italic> and higher expression levels of <italic>AASS</italic> transcripts in their blood before vaccination compared with infants who remained afebrile (Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6F</xref>). We also explored the ability of baseline transcriptomic data to predict subsequent vaccine‐induced immunity. The 200 transcripts, that contributed the most to the variance explained by the first PC, were used to train a SVR model to predict post‐vaccination MenB SBA titres (Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6G</xref> and Dataset <xref rid="msb20209888-sup-0013" ref-type="supplementary-material">EV12</xref>). The top 5 genes contributing to this model are shown in Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6I</xref>. This model was shown to predict SBA titres that correlated (<italic>r</italic> = 0.82, <italic>P</italic> = 0.007) with observed MenB‐specific SBA titres in an test set of individuals (not used to train model; Fig <xref rid="msb20209888-fig-0006" ref-type="fig">6H</xref>). We did not observe a difference in post‐vaccination MenB‐specific SBA titres between infants who experienced a fever within 24 h of vaccination and those who remained afebrile (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S11</xref>B).</p>
              </sec>
              <sec id="msb20209888-sec-0010">
                <title>4CMenB induces a greater magnitude of early pro‐inflammatory gene expression in mice when administered in combination with control immunisations</title>
                <p>In order to validate genes significantly differentially regulated 24 h post‐immunisation in infants, we proceeded to immunise mice with control vaccines, on their own or in combination with 4CMenB (test group), or with 4CMenB only and performed RNA‐sequencing on RNA derived from the peripheral blood taken at 24 h after the second dose. Mice in the test group exhibited greater perturbation of the transcriptome (695 DEGs vs PBS controls), compared with those receiving the 4CMenB vaccine alone (268 DEGs vs PBS controls) or control vaccines alone (one DEG vs PBS controls; Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S13</xref>A).</p>
                <p>Several genes encoding pattern recognition receptors (PRRs) and pro‐inflammatory signalling pathway components were differentially regulated between the 4CMenB‐containing combinations and the control vaccines (Fig <xref rid="msb20209888-fig-0007" ref-type="fig">7</xref>). Pathways analysis disclosed significantly enriched gene sets in all vaccine groups including IL‐1 signalling and toll‐like receptor signalling (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S13</xref>C). Pathway analysis revealed that the test group was associated with enrichment of several immune pathways including IL‐3, IL‐5 and GM‐CSF signalling, compared with the 4CMenB only group (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S13</xref>A).</p>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0007" orientation="portrait" position="float">
                  <label>Figure 7</label>
                  <caption>
                    <title>Selection of top differentially expressed genes identified in the mouse study</title>
                    <p>Boxplots represent the median with interquartile ranges. False discovery rate (FDR) is displayed above and was derived from a two‐sample Wilcoxon rank sum test (Benjamini–Hochberg correction). <italic>N</italic> = 6 mice per vaccine group.</p>
                  </caption>
                  <graphic id="nlm-graphic-17" xlink:href="MSB-16-e9888-g008"/>
                </fig>
                <p>Cell deconvolution analysis was performed with these samples to infer the composition of immune cells from whole blood gene signatures (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S14</xref>). A decrease in the proportion of most B‐cell subsets was observed in the test and 4CMenB only groups. Neutrophils were increased in both 4CMenB‐immunised groups but not the control immunisation group (Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S15</xref>).</p>
              </sec>
              <sec id="msb20209888-sec-0011">
                <title>Bacterial outer membrane components LPS and peptidoglycan recapitulate pyrogenicity profile evoked by 4CMenB vaccine</title>
                <p>Lipopolysaccharide (LPS), contained within the OMV component of the 4CMenB vaccine, has been identified as a potential source of vaccine reactogenicity (Dowling <italic>et al</italic>, <xref rid="msb20209888-bib-0017" ref-type="ref">2016</xref>). However, other components of the OMVs may also be pyrogenic, for example, naturally occurring OMVs contain peptidoglycan (van der Pol <italic>et al</italic>, <xref rid="msb20209888-bib-0090" ref-type="ref">2015</xref>). As we observed upregulation of <italic>Tlr2</italic>, <italic>Trem1</italic> and <italic>Pglyrp1</italic>, known receptors for peptidoglycan, we assessed the temperature profiles of mice following immunisation with LPS, peptidoglycan or LPS + peptidoglycan (Fig <xref rid="msb20209888-fig-0008" ref-type="fig">8</xref>). All LPS and peptidoglycan preparations evoked significant rises in temperature, with no rise in temperature observed in alum only, or unvaccinated, mice (Fig <xref rid="msb20209888-fig-0008" ref-type="fig">8</xref>). Temperature rises following peptidoglycan were transient, but the highest temperatures were observed in the peptidoglycan + LPS group (Fig <xref rid="msb20209888-fig-0008" ref-type="fig">8</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="msb20209888-fig-0008" orientation="portrait" position="float">
                  <label>Figure 8</label>
                  <caption>
                    <title>Mouse temperatures following administration of purified preparations of Gram‐negative bacteria outer membrane components</title>
                    <p>Boxplots depicting the change in temperature from baseline to 24 h after the second 1 μg dose of each of a variety of <italic>Escherichia coli</italic> lipopolysaccharide (LPS) and peptidoglycan (PGN) preparations, with and without alum, and combinations compared with 1/5 of the human dose of 4CMenB. Boxplots represent the median with interquartile ranges. Vaccine group medians at each time point were compared with baseline for that vaccine using a Wilcoxon signed‐rank test. *&lt; 0.05, **&lt; 0.01, ****&lt; 0.0001. <italic>N</italic> = 6 mice per vaccine group.</p>
                  </caption>
                  <graphic id="nlm-graphic-19" xlink:href="MSB-16-e9888-g009"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion" id="msb20209888-sec-0012">
              <title>Discussion</title>
              <p>Here we describe extensive blood transcriptional perturbation following infant vaccination. We reveal a prominent change to the blood transcriptome from 4 h that peaks at 24 h post‐vaccination, which is associated with a transient increase in peripheral blood neutrophils. We used a continuous temperature measurement device to describe significantly higher rates of fever in infants following 4CMenB plus control vaccines compared with control vaccines only. Furthermore, we detailed differences at both the transcriptomic and proteomic level, in infants who received the concomitant 4CMenB vaccine. Moreover, we showed enhanced early expression of a gene encoding a protein involved in leucocyte extravasation that was associated with fever following vaccination. Finally, we defined baseline whole blood gene signatures that were predictive of vaccine immunogenicity and reactogenicity.</p>
              <p>There are an increasing number of studies describing transcriptional responses to immunisation in adults (Obermoser <italic>et al</italic>, <xref rid="msb20209888-bib-0057" ref-type="ref">2013</xref>; Nakaya <italic>et al</italic>, <xref rid="msb20209888-bib-0053" ref-type="ref">2015</xref>; O'Connor <italic>et al</italic>, <xref rid="msb20209888-bib-0058" ref-type="ref">2017</xref>). However, there are few data describing transcriptional regulation following infant immunisation—despite most vaccination programmes being targeted to this population (ECDC, <xref rid="msb20209888-bib-0018" ref-type="ref">2018</xref>; WHO, <xref rid="msb20209888-bib-0097" ref-type="ref">2018</xref>). Here we present the first whole‐transcriptome description of infant blood samples taken following immunisation. Consistent with previous studies in older children and adults, we observed an initial upregulation of genes involved in innate recognition of microbial motifs and the downregulation of genes associated with T cells (Fuller <italic>et al</italic>, <xref rid="msb20209888-bib-0025" ref-type="ref">2007</xref>; Obermoser <italic>et al</italic>, <xref rid="msb20209888-bib-0057" ref-type="ref">2013</xref>; Nakaya <italic>et al</italic>, <xref rid="msb20209888-bib-0054" ref-type="ref">2016</xref>). We also revealed that much of the blood transcriptional perturbation occurring within 24 h of infant vaccination was attributable to post‐vaccination neutrophilia. While neutrophils are principally described as short‐lived effector cells, they also express numerous innate recognition receptors and produce a vast array of immune mediators and it has even recently been shown that they can be induced to present antigens to T cells (Mantovani <italic>et al</italic>, <xref rid="msb20209888-bib-0048" ref-type="ref">2011</xref>; Vono <italic>et al</italic>, <xref rid="msb20209888-bib-0093" ref-type="ref">2017</xref>). The role of this transient increases in circulating neutrophils on the regulation of vaccine responses is unclear; however, neutrophils migrate rapidly to the site of vaccination and are the first to transport antigen to afferent lymph nodes (Calabro <italic>et al</italic>, <xref rid="msb20209888-bib-0010" ref-type="ref">2011</xref>).</p>
              <p>Consistent with previous studies, fever (≥ 38°C) was more common in infants vaccinated with 4CMenB, given concomitantly with control (PCV13 + DTaP‐IPV‐Hib) immunisations, than in infants who received control immunisations alone (Gossger <italic>et al</italic>, <xref rid="msb20209888-bib-0029" ref-type="ref">2012</xref>). Fever has an important role in fighting off infection (Evans <italic>et al</italic>, <xref rid="msb20209888-bib-0021" ref-type="ref">2015</xref>). Furthermore, this rise in body temperature has been implicated in a positive feedback loop during the early stages of inflammatory responses (Evans <italic>et al</italic>, <xref rid="msb20209888-bib-0021" ref-type="ref">2015</xref>). Fever‐range hyperthermia in mice increases circulating neutrophil counts and promotes extravasation of leucocytes via L‐selection (Wang <italic>et al</italic>, <xref rid="msb20209888-bib-0094" ref-type="ref">1998</xref>; Capitano <italic>et al</italic>, <xref rid="msb20209888-bib-0011" ref-type="ref">2012</xref>). Here, we show the gene encoding L‐selectin (<italic>SELL</italic>) is upregulated, 4 h after vaccination, in peripheral blood from infants who experience fever within 24 h of vaccination compared with those who remained afebrile. The upregulation of <italic>SELL</italic> suggests that post‐vaccination fever may be associated with enhanced leucocyte extravasation and neutrophil recruitment to the site of inflammation (i.e. vaccination site) (Zarbock &amp; Ley, <xref rid="msb20209888-bib-0102" ref-type="ref">2008</xref>). There are data suggesting post‐vaccination fever can be associated with increased immunogenicity (Andrews <italic>et al</italic>, <xref rid="msb20209888-bib-0002" ref-type="ref">2011</xref>; Li‐Kim‐Moy <italic>et al</italic>, <xref rid="msb20209888-bib-0045" ref-type="ref">2018</xref>). Correspondingly, prophylactic use of antipyretics has been associated with reduced vaccine immunogenicity, albeit the clinical relevance of this effect is debatable (Prymula <italic>et al</italic>, <xref rid="msb20209888-bib-0063" ref-type="ref">2009</xref>; Prymula <italic>et al</italic>, <xref rid="msb20209888-bib-0064" ref-type="ref">2014</xref>; Li‐Kim‐Moy <italic>et al</italic>, <xref rid="msb20209888-bib-0045" ref-type="ref">2018</xref>). Moreover, as antipyretics (such as acetaminophen) have anti‐inflammatory, as well as antipyretic effects, the mechanisms underlying their relationship with vaccine immunogenicity are unclear (Prymula <italic>et al</italic>, <xref rid="msb20209888-bib-0064" ref-type="ref">2014</xref>; Saleh <italic>et al</italic>, <xref rid="msb20209888-bib-0072" ref-type="ref">2016</xref>).</p>
              <p>Next, we explored why concomitant 4CMenB is associated with increased reactogenicity by comparing the blood transcriptome profiles of infants who received this vaccine with those who received control vaccines alone. While the transcriptional changes induced by the two vaccine regimens evaluated were broadly similar, three genes showed statistically significant differences (FDR &lt; 0.05) in their regulation: <italic>ENTPD7</italic> (24 h), <italic>IGHG3</italic> (day 7) and <italic>IGLV9‐49</italic> (day 7). The first of these, <italic>ENTPD7</italic>, was significantly upregulated 24 h post‐vaccination in infants who received 4CMenB compared with infants who received the control vaccines alone. <italic>ENTPD7</italic> encodes an ectonucleotidase, which is an ATP hydrolysing enzyme. Extracellular ATP modulates multiple immune cell functions, via purinergic receptors, and is tightly regulated by ectonucleotidases (Chen <italic>et al</italic>, <xref rid="msb20209888-bib-0013" ref-type="ref">2006</xref>). Concurrently, plasma levels of G‐CSF, the prototypical cytokine involved in the production and mobilisation of neutrophils, were elevated in those who received concomitant 4CMenB compared with the control vaccine alone (Bendall &amp; Bradstock, <xref rid="msb20209888-bib-0005" ref-type="ref">2014</xref>). These data support differences in neutrophil motility and chemotaxis between these vaccine groups.</p>
              <p>We observed a raised CRP 24 h post‐vaccination in both the test (median 45.84 mg/l; IQR: 27.17–54.72) and control (median 22.00 mg/l; IQR: 12.21–25.11), compared with the normal reference range for this plasma protein (0–5 mg/l). Moreover, CRP levels were higher in the test group than the control group, 24 h post‐vaccination (FDR = 0.01). Importantly, an elevated CRP (&gt; 5mg/l) was common 24 h post‐vaccination—CRP levels and neutrophil counts are commonly used as diagnostic markers in suspected sepsis—these findings needs to be taken into consideration when assessing febrile infants following vaccination (Van den Bruel <italic>et al</italic>, <xref rid="msb20209888-bib-0089" ref-type="ref">2011</xref>; Faix, <xref rid="msb20209888-bib-0022" ref-type="ref">2013</xref>). These data are consistent with a recent report showing increased CRP levels from 12 to 72 h post‐vaccination, in premature infants administered 4CMenB with routine vaccines (Kent <italic>et al</italic>, <xref rid="msb20209888-bib-0039" ref-type="ref">2019</xref>).</p>
              <p>In addition to G‐CSF and CRP, plasma protein levels of IL‐6 and IL‐1RA were also elevated in the test vaccine group compared with the control vaccine group. IL‐6 is the archetypal member of the IL‐6 cytokine family, with a central role in inflammation and immunity (Jones &amp; Jenkins, <xref rid="msb20209888-bib-0036" ref-type="ref">2018</xref>). IL‐6 can be produced by local sites of inflammation, travel through the blood to the liver where it induces a range of acute phase proteins, such as CRP (Heinrich <italic>et al</italic>, <xref rid="msb20209888-bib-0031" ref-type="ref">1990</xref>). Conversely, IL‐1RA is an IL‐1R antagonist, so it is conceivable that this is acting to limit inflammation through some negative feedback loop (Garlanda <italic>et al</italic>, <xref rid="msb20209888-bib-0026" ref-type="ref">2013</xref>).</p>
              <p>We aimed to validate the infant gene expression data using a murine model. We immunised mice with control immunisations, with or without the 4CMenB test vaccine, and included a 4CMenB only group. Firstly, we showed a greater magnitude of change in the blood gene profiles of mice immunised with 4CMenB vaccine than those immunised with control immunisations only. Moreover, cell deconvolution analysis showed mice immunised with 4CMenB also had an increase in their neutrophil gene signature, which was not observed in mice immunised with control immunisations only. Notably, the peptidoglycan receptor <italic>Pglyrp1</italic> and the triggering receptor expressed on myeloid cells <italic>Trem1</italic> were amongst the most upregulated genes in mice immunised with 4CMenB. PGLYRP1 has been characterised as a ligand for the TREM‐1 receptor (Pelham <italic>et al</italic>, <xref rid="msb20209888-bib-0060" ref-type="ref">2014</xref>). TREM‐1 is upregulated on neutrophils and monocytes during bacterial infection and, when ligated, acts synergistically with LPS to amplify the pro‐inflammatory response (Bouchon <italic>et al</italic>, <xref rid="msb20209888-bib-0009" ref-type="ref">2001</xref>). In order for PGLYRP1 to stimulate TREM‐1, it must be cross‐linked with peptidoglycan, whereby it induces cytokine production in neutrophils and macrophages (Read <italic>et al</italic>, <xref rid="msb20209888-bib-0066" ref-type="ref">2015</xref>).</p>
              <p>In the infant study, we found <italic>PGLYRP1</italic> and <italic>TREM1</italic> to be significantly upregulated 4 and 24 h post‐vaccination in both vaccine groups. Of note, 4 h after vaccination, <italic>PGLYRP1</italic> was one of the most differentially regulated genes in the concomitant 4CMenB group compared with the control vaccine group. Although <italic>PGLYRP1</italic> expression is restricted to neutrophils (in blood cells), correcting for neutrophil counts did not remove the difference in expression seen between the concomitant 4CMenB group and the control group (Liu <italic>et al</italic>, <xref rid="msb20209888-bib-0046" ref-type="ref">2000</xref>). <italic>PGLYRP1</italic> expression is upregulated by stimulation with peptidoglycan (a cell wall component of both Gram‐positive and Gram‐negative bacteria) (Uehara <italic>et al</italic>, <xref rid="msb20209888-bib-0086" ref-type="ref">2005</xref>). Peptidoglycan fragments are known to covalently attach to some of the purified pneumococcal polysaccharides within PCV13 (Sørensen <italic>et al</italic>, <xref rid="msb20209888-bib-0079" ref-type="ref">1990</xref>). Moreover, while the peptidoglycan content of detergent extracted OMVs (component of 4CMenB) has not been described, naturally occurring OMVs do contain peptidoglycan (van der Pol <italic>et al</italic>, <xref rid="msb20209888-bib-0090" ref-type="ref">2015</xref>). One explanation for the differences seen in <italic>PGLYRP1</italic> regulation between those who received concomitant 4CMenB and those who received control vaccines alone is a dose‐dependent difference in the amount of peptidoglycan delivered in the study vaccine regimens. Here, in mice, we showed that peptidoglycan alone could evoke a rise in temperature and presented data suggesting an additive pyrogenic effect of administration of LPS plus peptidoglycan. These data suggest that the increased reactogenicity of 4CMenB when given concomitantly with other immunisations, compared with 4CMenB alone (Gossger <italic>et al</italic>, <xref rid="msb20209888-bib-0029" ref-type="ref">2012</xref>) may be attributable to the additive effects of pyrogenic components of these vaccines.</p>
              <p>A noteworthy feature of infant 4CMenB vaccination is that when administered alone, fever rates are similar to those seen after other infant immunisation regimens (PCV7 and DTaP‐IPV‐Hib) but when given concomitantly with other childhood vaccines, fever rates are increased (Gossger <italic>et al</italic>, <xref rid="msb20209888-bib-0029" ref-type="ref">2012</xref>). This additional reactogenicity has been attributed to the OMV component, as concomitant vaccination with the recombinant 4CMenB proteins and other routine vaccines (DTaP‐HBV‐IPV/Hib and PCV7) displays lower reactogenicity than concomitant OMV‐containing 4CMenB(Esposito <italic>et al</italic>, <xref rid="msb20209888-bib-0020" ref-type="ref">2014</xref>). It has been suggested that attenuating LPS, by genetic modification (e.g. <italic>lpxL1</italic>), may ameliorate the reactogenicity of the OMV‐containing vaccines (Dowling <italic>et al</italic>, <xref rid="msb20209888-bib-0017" ref-type="ref">2016</xref>). However, <italic>IL1β</italic> (a pro‐inflammatory cytokine and endogenous pyrogen) has been found to be upregulated similarly in mice immunised with native and <italic>lpxL1</italic> mutant OMV‐containing vaccines, suggesting that non‐endotoxin pyrogens, such as peptidoglycan, may also contribute to OMV reactogenicity (Sheerin <italic>et al</italic>, <xref rid="msb20209888-bib-0074" ref-type="ref">2019</xref>). Moreover, in mice, the concomitant regimen was associated with increased gene perturbation compared with 4CMenB vaccine administered alone and enhancement of pathways such as interleukin‐3, ‐5 and GM‐CSF signalling. These findings highlight the importance of fully characterising the pyrogen content of vaccines and understanding how these may interact when administered concomitantly. Despite substantial differences in peripheral blood neutrophil abundance, between mice and human infants (female 8‐week C57BL/6 mice, neutrophil count ~ 0.25 × 10<sup>9</sup>/l; 2‐ to 6‐month human infants, neutrophil count 1–8.5 × 10<sup>9</sup>/l), we observed similar trends in gene expression profiles between the species (<xref rid="msb20209888-bib-0091" ref-type="ref">Virgo</xref>; The Jackson Laboratory, <xref rid="msb20209888-bib-0083" ref-type="ref">2007</xref>). While the mouse model has clear limitations, these data support the utility of this model in exploring experimental procedures not amenable in human subjects.</p>
              <p>Consistent with previous reports, we observed the upregulation of genes associated with terminally differentiated, antibody‐secreting B cells (plasma cells) at 7 days post‐vaccination (Obermoser <italic>et al</italic>, <xref rid="msb20209888-bib-0057" ref-type="ref">2013</xref>; O'Connor <italic>et al</italic>, <xref rid="msb20209888-bib-0058" ref-type="ref">2017</xref>). Of note, we identified a particular gene encoding an immunoglobulin light chain molecule, <italic>IGLV9‐49,</italic> that was upregulated after vaccination with 4CMenB vaccine compared with control vaccines alone. The immunoglobulin heavy chain is often thought to dominate antigen recognition (Xu &amp; Davis, <xref rid="msb20209888-bib-0100" ref-type="ref">2000</xref>). However, the prominence of the light chain in determining the specificity and affinity of antigen binding has also been demonstrated (Song <italic>et al</italic>, <xref rid="msb20209888-bib-0077" ref-type="ref">2000</xref>; Senn <italic>et al</italic>, <xref rid="msb20209888-bib-0073" ref-type="ref">2003</xref>).</p>
              <p>Previous studies in adults have suggested baseline transcriptional signatures may be predictive of subsequent responses to vaccines (Tsang <italic>et al</italic>, <xref rid="msb20209888-bib-0085" ref-type="ref">2014</xref>). Here we used machine learning to build models that were able to predict infant immunological (MenB‐specific SBA titres) and physiological (fever) responses following vaccination, using pre‐vaccination peripheral blood gene signatures as input variables. The most significant contributor to the baseline gene signature predictive of post‐vaccination fever was <italic>APBA3</italic>, an important gene in the function and migration of macrophages and inflammatory monocytes via the glycolytic pathway (Hara <italic>et al</italic>, <xref rid="msb20209888-bib-0030" ref-type="ref">2011</xref>). Mouse knockouts of <italic>Apba3</italic> have defective macrophages, that are resistant to LPS and fail to migrate to sites of acute inflammation (Hara <italic>et al</italic>, <xref rid="msb20209888-bib-0030" ref-type="ref">2011</xref>; Uematsu <italic>et al</italic>, <xref rid="msb20209888-bib-0087" ref-type="ref">2016</xref>). Interestingly, 3/5 (<italic>FUZ, MKS1</italic> and <italic>KDM7A</italic>) of the most important contributors to the baseline gene signature predictive of MenB‐specific SBA titres have also been shown to be differentially expressed in monocytes stimulated with LPS (Cepika <italic>et al</italic>, <xref rid="msb20209888-bib-0012" ref-type="ref">2017</xref>).</p>
              <p>This project described gene regulation following immunisation of a healthy cohort of Caucasian infants, at a single site in the United Kingdom. The generalisability of these finding to infants from different ethnic, geographical, genetic and health backgrounds is unknown. We chose to characterise the blood transcriptome following immunisations given at 4 months of age, as previous data had shown the greatest rise in MenB‐specific SBA titre and the greatest reactogenicity to occur following a second dose of 4CMenB vaccine (Gossger <italic>et al</italic>, <xref rid="msb20209888-bib-0029" ref-type="ref">2012</xref>; Snape <italic>et al</italic>, <xref rid="msb20209888-bib-0076" ref-type="ref">2013</xref>). Therefore, we are limited to evaluating the transcriptome around this dose and do not have data related to the first dose of 4CMenB. In infants, we exclusively looked at 4CMenB given concomitantly, as this is how this vaccine has been implemented into the UK infant vaccination programme. However, we supplemented our finding by exploring gene regulation induced by this vaccine when administered alone in a mouse model. We conducted bulk sequencing of whole blood samples, which presents difficulties in deducing whether changes in gene expression reflect changes at the cellular level or changes in cell abundances. To ameliorate this, we employed a computational approach to deconvolute cellular abundances which we showed to perform well for neutrophils; however, this approach has a number of limitations such as lack of fidelity of cell reference profiles and phenotypic plasticity (Newman <italic>et al</italic>, <xref rid="msb20209888-bib-0055" ref-type="ref">2015</xref>). Caution is advised when interpreting these deconvoluted cell proportions; e.g. while the deconvoluted neutrophil proportions correlated well with actual neutrophil counts, the use of a basis/signature matrix exclusively generated from microarray datasets (LM22 or immunoStates) resulted in a systematic underestimation of neutrophil proportions in this RNA‐seq dataset. In conclusion, these findings provide evidence of a relationship between particular vaccine components and increases in circulating neutrophils and their chemotaxis and post‐vaccination fever. These discoveries could have important implications in the design of future vaccines.</p>
            </sec>
            <sec sec-type="materials-and-methods" id="msb20209888-sec-0013">
              <title>Material and Methods</title>
              <sec id="msb20209888-sec-0014">
                <title>Reagents and Tools table</title>
                <p>
                  <table-wrap id="nlm-table-wrap-1" xml:lang="en" orientation="portrait" position="anchor">
                    <table frame="hsides" rules="groups">
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000" span="1"/>
                      <thead valign="top">
                        <tr style="border-bottom:solid 1px #000000">
                          <th align="left" valign="top" rowspan="1" colspan="1">Reagent/Resource</th>
                          <th align="left" valign="top" rowspan="1" colspan="1">Reference or Source</th>
                          <th align="left" valign="top" rowspan="1" colspan="1">Identifier or Catalog Number</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" colspan="3" rowspan="1">
                            <bold>Experimental Models</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">C57BL/6J (<italic>Mus musculus</italic>)</td>
                          <td align="left" rowspan="1" colspan="1">Harlan, UK</td>
                          <td align="left" rowspan="1" colspan="1">N/A</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="3" rowspan="1">
                            <bold>Chemicals, Enzymes and other reagents</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">PCV13</td>
                          <td align="left" rowspan="1" colspan="1">Pfizer</td>
                          <td align="left" rowspan="1" colspan="1">Prevenar®</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">DTaP‐IPV‐Hib</td>
                          <td align="left" rowspan="1" colspan="1">Sanofi Pasteur MSD</td>
                          <td align="left" rowspan="1" colspan="1">Pediacel®</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">MenC‐TT</td>
                          <td align="left" rowspan="1" colspan="1">Baxter Vaccines</td>
                          <td align="left" rowspan="1" colspan="1">NeisVac‐C®</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Oral rotavirus vaccine</td>
                          <td align="left" rowspan="1" colspan="1">GSK</td>
                          <td align="left" rowspan="1" colspan="1">Rotarix®</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1"><italic>Escherichia coli</italic> lipopolysaccharide</td>
                          <td align="left" rowspan="1" colspan="1">Invivogen</td>
                          <td align="left" rowspan="1" colspan="1">tlrl‐eblps</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1"><italic>Escherichia coli</italic> lipopolysaccharide ultrapure</td>
                          <td align="left" rowspan="1" colspan="1">Invivogen</td>
                          <td align="left" rowspan="1" colspan="1">tlrl‐3pelps</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1"><italic>Escherichia coli</italic> peptidoglycan</td>
                          <td align="left" rowspan="1" colspan="1">Invivogen</td>
                          <td align="left" rowspan="1" colspan="1">tlrl‐pgneb</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Alum</td>
                          <td align="left" rowspan="1" colspan="1">Invivogen</td>
                          <td align="left" rowspan="1" colspan="1">vac‐alu‐250</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">MILLIPLEX® Human cytokine/chemokine panel</td>
                          <td align="left" rowspan="1" colspan="1">Merck</td>
                          <td align="left" rowspan="1" colspan="1">HCYTOMAG‐60K‐23C</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">MILLIPLEX® human CVD panel 3</td>
                          <td align="left" rowspan="1" colspan="1">Merck</td>
                          <td align="left" rowspan="1" colspan="1">HCVD3MAG‐67K</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="3" rowspan="1">
                            <bold>Software</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HISAT2</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="https://daehwankimlab.github.io/hisat2/manual/">https://daehwankimlab.github.io/hisat2/manual/</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 2.0.5</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">STAR</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 2.6</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SortMeRNA</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="https://bioinfo.lifl.fr/RNA/sortmerna/">https://bioinfo.lifl.fr/RNA/sortmerna/</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 2.1</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cibersortx</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="https://cibersortx.stanford.edu">https://cibersortx.stanford.edu</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 1.0</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">ImmQuant</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="http://csgi.tau.ac.il/ImmQuant/">http://csgi.tau.ac.il/ImmQuant/</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 25.01.2017</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HISAT‐genotype</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="https://daehwankimlab.github.io/hisat-genotype/">https://daehwankimlab.github.io/hisat‐genotype/</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 1.0.1‐beta</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">R</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org">https://www.r‐project.org</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 3.4.4</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">edgeR</td>
                          <td align="left" rowspan="1" colspan="1">Robinson <italic>et al</italic> (<xref rid="msb20209888-bib-0068" ref-type="ref">2010</xref>)</td>
                          <td align="left" rowspan="1" colspan="1">version 3.20.9</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Limma</td>
                          <td align="left" rowspan="1" colspan="1">Law <italic>et al</italic> (<xref rid="msb20209888-bib-0044" ref-type="ref">2014</xref>)</td>
                          <td align="left" rowspan="1" colspan="1">version 3.34.9</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Caret</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="http://topepo.github.io/caret/index.html">http://topepo.github.io/caret/index.html</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 6.0.80</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">XGR</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="http://xgr.r-forge.r-project.org">http://xgr.r‐forge.r‐project.org</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 1.1.4</td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tmod</td>
                          <td align="left" rowspan="1" colspan="1">
                            <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/tmod/tmod.pdf">https://cran.r‐project.org/web/packages/tmod/tmod.pdf</ext-link>
                          </td>
                          <td align="left" rowspan="1" colspan="1">version 0.36</td>
                        </tr>
                        <tr>
                          <td align="left" colspan="3" rowspan="1">
                            <bold>Other</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Illumina HiSeq4000</td>
                          <td align="left" rowspan="1" colspan="1">Illumina</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" style="padding-left:10%" rowspan="1" colspan="1">iButton</td>
                          <td align="left" rowspan="1" colspan="1">iButton™</td>
                          <td align="left" rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </table-wrap>
                </p>
              </sec>
              <sec id="msb20209888-sec-0015">
                <title>Methods and Protocols</title>
                <sec id="msb20209888-sec-0016">
                  <title>Clinical study design</title>
                  <p>This study was a randomised, open‐label, single‐centre, descriptive study (NCT02080559) conducted by the Oxford Vaccine Group, University of Oxford. One hundred and eighty‐seven healthy infants aged 8–12 weeks who had not yet received their routine infant immunisations were enrolled. Infants were randomly assigned (1:1) to a control group (to receive their routine vaccines according to the UK immunisation schedule, Fig <xref rid="msb20209888-fig-0001" ref-type="fig">1</xref>, i.e. PCV13 [Prevenar®, Pfizer] and DTaP‐IPV‐Hib [Pediacel®, Sanofi Pasteur MSD] at 2 and 4 months of age) or a test group (4CMenB [GSK Vaccines] plus aforementioned routine/control vaccines at 2 and 4 months of age). Control vaccines were administered in the anterolateral left thigh, while 4CMenB was administered intramuscularly in the anterolateral right thigh. Both test and control groups also received oral rotavirus vaccine (Rotarix, GSK) at 2 and 3 months; and MenC‐TT at 3 months (NeisVac‐C, Baxter Vaccines; Fig <xref rid="msb20209888-fig-0001" ref-type="fig">1</xref> and Appendix Fig <xref rid="msb20209888-sup-0001" ref-type="supplementary-material">S1</xref>). PCV13 and DTaP‐IPV‐Hib vaccines contained aluminium phosphate adjuvant; MenC‐TT and 4CMenB vaccines contained aluminium hydroxide adjuvant. In this study, paracetamol was not given prophylactically but post‐vaccination paracetamol/ibuprofen was administrated at the parent's/guardian's discretion.</p>
                  <p>All participants were Caucasian infants (defined as having two Caucasian parents). Ethnicity is a factor that is known to influence baseline gene expression characteristics, and contemporary gene expression analysis methods frequently exclude data from different ethnic groups (to reduce data heterogeneity) from downstream analysis (Spielman <italic>et al</italic>, <xref rid="msb20209888-bib-0080" ref-type="ref">2007</xref>). Therefore, it seemed unethical to recruit participants whose data were not likely to be included in differential gene expression analysis. Blood samples for transcriptomic and proteomic analyses were taken at 4 months of age, 7 days or fewer before a second dose of 4CMenB in the test group, then either 4 h, 24 h, 3 days or 7 days post‐vaccination (Fig <xref rid="msb20209888-fig-0001" ref-type="fig">1</xref>). This sub‐allocation was to minimise the number of blood tests each infant received. Sub‐allocation was dependent on parental availability; however, re‐allocation was possible if an earlier visit was unsuccessful. Blood samples for immunogenicity were taken at 5 months of age. Written informed consent was obtained from the parent or legal guardian, after a detailed explanation of the study. A national research ethics committee (South Central ‐ Oxford A, 14/SC/0077) approved this study.</p>
                </sec>
                <sec id="msb20209888-sec-0017">
                  <title>Serum bactericidal assays</title>
                  <p>Plasma samples collected 1 month after a second dose of 4CMenB in the test vaccine group were assessed for capsular group B meningococci SBA activity (plasma or serum can be used in this assay) (Borrow <italic>et al</italic>, <xref rid="msb20209888-bib-0008" ref-type="ref">2005</xref>). SBA using human complement was performed at Vaccine Evaluation Unit, Public Health England, Manchester using capsular group B meningococci strain H44/76‐SL (Borrow <italic>et al</italic>, <xref rid="msb20209888-bib-0008" ref-type="ref">2005</xref>). The lower limit of quantification for the SBA assays was 2; samples without detectable SBA activity were assigned an arbitrary value of 1.</p>
                </sec>
                <sec id="msb20209888-sec-0018">
                  <title>Full blood count</title>
                  <p>The clinical haematology laboratory (Oxford University Trust Hospital NHS foundation trust) performed the full blood counts (FBC).</p>
                </sec>
                <sec id="msb20209888-sec-0019">
                  <title>C‐reactive protein</title>
                  <p>The clinical biochemistry laboratory (Oxford University Trust Hospital NHS foundation trust) performed the C‐reactive protein (CRP) assessment using spectrophotometry.</p>
                </sec>
                <sec id="msb20209888-sec-0020">
                  <title>Reactogenicity measure (iButton)</title>
                  <p>The body temperature of participants at the time of their 4‐month immunisations was recorded by using a wireless continuous temperature monitoring system (iButton®). The iButton® is a non‐invasive device for human skin temperature measurements, that has the capacity to record a temperature reading each minute over a 24 h period. In this study, the iButton® was applied to the infant's abdomen and used to record temperatures in the first 24 h post‐vaccination. Fever was defined as any iButton® recording of ≥ 38°C within the first 24 h of vaccination. The chi‐square test was used to compare the iButton® fever rates between the control vaccine and 4CMenB + control vaccine groups. Time to first fever in both groups was illustrated using Kaplan–Meier failure curves, and the log‐rank test was used to compare the groups. In the transcriptomic analysis, only iButton® datasets with &lt; 90 min of missing data were considered “complete” and included in the reactogenicity analysis (to minimise misclassification).</p>
                </sec>
                <sec id="msb20209888-sec-0021">
                  <title>Mouse immunisations</title>
                  <p>All procedures were performed in accordance with the terms of the UK Home Office Animals Act Project License. The University of Oxford Animal Care and Ethical Review Committee approved procedures. Mice were immunised intramuscularly under general anaesthesia. Cardiac bleeds were performed under general anaesthesia followed by cervical dislocation. A mouse immunisation model was designed to recapitulate the human infant study, previously described (Sheerin <italic>et al</italic>, <xref rid="msb20209888-bib-0074" ref-type="ref">2019</xref>). Groups of six 6‐ to 8‐week old female C57BL/6 mice (Harlan, UK) were immunised intramuscularly with 1/15 of the human dose (to comply with the maximum volume of vaccine allowed per mouse outlined in the project licence) for vaccine combination comparisons—4CMenB only, control group (routine vaccines only), 4CMenB + control vaccines (test group) and phosphate‐buffered saline (PBS control)—or 1/5 of the human dose for single vaccine/antigen comparisons—<italic>E. coli</italic> LPS (Invivogen, France, tlrl‐eblps) in alum (Invivogen, France, vac‐alu‐250), ultrapure <italic>E. coli</italic> LPS (Invivogen, France, tlrl‐3pelps) in alum, <italic>E. coli</italic> peptidoglycan (Invivogen, tlrl‐pgneb) adsorbed on alum, combination of alum‐adsorbed peptidoglycan and LPS, alum only or no immunisations at all (naïve control; Dataset <xref rid="msb20209888-sup-0002" ref-type="supplementary-material">EV1</xref>). Blood samples were taken 24 h after the second dose (day 22) and stored in RNAprotect Animal Blood Tubes (QIAGEN) containing RNA‐stabilising reagent and incubated at room temperature for 2 h to lyse blood cells.</p>
                </sec>
                <sec id="msb20209888-sec-0022">
                  <title>Human infant RNA Sequencing</title>
                  <p>Peripheral blood (up to 1.5 ml) was collected into a reduced volume PAXgene™ RNA stabilisation reagent (ratio of blood to PAXgene equivalent to manufacturer's specifications). Total RNA was extracted using the Blood RNA Kit (PreAnalytiX, Switzerland), using the automated protocol (QIAcube instrument, QIAGEN, Germany). The ribodepleted and globin depleted fraction were selected from the total RNA using Ribo‐Zero™ Gold rRNA removal Kit (Illumina, USA). RNA was converted to cDNA, second‐strand cDNA synthesis incorporated dUTP. The cDNA was end‐repaired, A‐tailed and adapter‐ligated and prior to amplification, samples underwent uridine digestion (to ensure strand‐specific sequencing). The prepared libraries were size selected, multiplexed and quality‐controlled before 100bp paired‐end sequencing (HiSeq4000). The multiplexing blocking strategy is available with the raw sequencing data (Gene Expression Omnibus, GSE131929). Sequencing was conducted at the Wellcome Trust Centre for Human Genetics (Oxford, UK).</p>
                  <p>The sequencing data (fastq) files were aligned against the whole human (<italic>Homo sapiens</italic>) genome build GRCh38 (<ext-link ext-link-type="uri" xlink:href="https://ccb.jhu.edu/software/hisat2/index.shtml">https://ccb.jhu.edu/software/hisat2/index.shtml</ext-link>), using HISAT2 (version 2.0.5) (Pertea <italic>et al</italic>, <xref rid="msb20209888-bib-0061" ref-type="ref">2016</xref>). Gene counting was conducted using the HTSeq (version 0.9.1), utilising human gene annotation gtf (General Transfer Format) version GRCh38.88 (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">www.ensembl.org</ext-link>). To remove genes with very low counts across most libraries, only genes with an abundance of more than three counts per million in nine or more samples were carried forward. Genes assigned a “gene biotype” of ribosomal RNA (rRNA), sex chromosome genes, mitochondrial RNA or haemoglobin were excluded from downstream analysis. Human leucocyte antigen typing of RNA‐sequencing data using HISAT‐genotype (version 1.0.1‐beta) was used to check correct pairing of pre‐ and post‐vaccination samples (preprint: Kim <italic>et al</italic>, <xref rid="msb20209888-bib-0040" ref-type="ref">2018</xref>).</p>
                </sec>
                <sec id="msb20209888-sec-0023">
                  <title>Human infant proteome analysis</title>
                  <p>Plasma cytokines were measured at baseline and 4 and 24 h post‐vaccination, in all participants for whom plasma was available. Prior to proteome measurement, plasma samples were thawed at room temperature and then clarified by spinning at 10,000 <italic>g</italic> for 15 min at 4ºC to remove any residual platelets and debris.</p>
                  <p>Twenty‐six cytokines were measured in multiplex using Luminex® technology (MILLIPLEX® Multiplex Assays, Merck, USA). The Human cytokine/chemokine panel (cat # HCYTOMAG‐60K‐23C) and human CVD panel 3 (cat # HCVD3MAG‐67K) were used to measure the following plasma proteins: L‐selectin, epidermal growth factor (EGF), transforming growth factor alpha (TGF‐α), granulocyte colony‐stimulating factor (G‐CSF), granulocyte–macrophage colony‐stimulating factor (GM‐CSF), fractalkine (FKN), interferon‐γ (IFNγ), GRO, interleukin‐1α (IL‐1α), interleukin‐1β (IL‐1β), interleukin‐2 (IL‐2), interleukin‐3 (IL‐3), interleukin‐4 (IL‐4), interleukin‐5 (IL‐5), interleukin‐6 (IL‐6), interleukin‐8 (IL‐8), interleukin‐10 (IL‐10), interleukin‐13 (IL‐13), interleukin‐17A (IL‐17A), interleukin‐1 receptor antagonist (IL‐1RA), IP‐10/CXCL10, tumour necrosis factor alpha (TNF‐α) and soluble CD‐40 ligand (sCD40L).</p>
                  <p>Samples and standard curves were run in duplicate. Mean fluorescence intensity (MFI) was read on a MagPix® (Luminex Corporation, USA) instrument. MFI was converted to concentration based on standard curves via the xPonent version 4.2 software (Luminex Corporation, USA) using default settings (logistic 5P weighted curve). Average concentrations were calculated for samples run in duplicate. A two‐sample Wilcoxon rank sum test was applied to compare post‐vaccination plasma protein levels between the concomitant 4CMenB and control vaccine groups.</p>
                </sec>
                <sec id="msb20209888-sec-0024">
                  <title>Mouse RNA sequencing</title>
                  <p>RNA was extracted from whole blood samples using a Mouse RiboPure™‐Blood RNA Isolation Kit (Ambion, USA). Samples were depleted of α‐ and β‐globin messenger RNA (mRNA) transcripts using a GLOBINclear™ Mouse/Rat Kit, (Ambion, USA). Polyadenylated mRNA transcripts were selected by oligo (dT) beads, uridine digested, converted to complementary DNA, amplified and labelled using a TotalPrepTM‐96 RNA Amplification Kit (Illumina, USA). The prepared libraries were size selected for 75 bp fragments and multiplexed before paired‐end sequencing using an Illumina HiSeq4000 (Illumina, USA), at the Wellcome Trust Centre for Human Genetics (Oxford, UK). Reads were aligned to the mouse (<italic>M. musculus</italic>) GRCm38 reference assembly and annotation (release 93, <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">http://www.ensembl.org</ext-link>) using STAR v2.6 (Dobin <italic>et al</italic>, <xref rid="msb20209888-bib-0016" ref-type="ref">2013</xref>). Reads per gene were determined simultaneously by using the STAR “‐quantMode GeneCounts” option. Counts were estimated at the gene level. Lowly expressed genes (fewer than 0.5 reads per million in 2 samples) were filtered from the data.</p>
                </sec>
                <sec id="msb20209888-sec-0025">
                  <title>Differential gene expression analysis</title>
                  <p>Differential gene expression was undertaken using the R Bioconductor packages “edgeR” and “limma” (Robinson <italic>et al</italic>, <xref rid="msb20209888-bib-0068" ref-type="ref">2010</xref>; McCarthy <italic>et al</italic>, <xref rid="msb20209888-bib-0050" ref-type="ref">2012</xref>; R core team, <xref rid="msb20209888-bib-0065" ref-type="ref">2013</xref>; Ritchie <italic>et al</italic>, <xref rid="msb20209888-bib-0067" ref-type="ref">2015</xref>). RNA‐sequencing data were normalised for RNA composition using trimmed mean of M‐value (TMM) method (Robinson &amp; Oshlack, <xref rid="msb20209888-bib-0069" ref-type="ref">2010</xref>). Data were transformed using the limma “voom” function. A linear model was fitted to the data using the limma “lmFit” function using the empirical Bayes method to borrow information between genes (Ritchie <italic>et al</italic>, <xref rid="msb20209888-bib-0067" ref-type="ref">2015</xref>). For the human study, paired analysis was conducted to compare pre‐ and post‐vaccination samples at each of the study time points and the statistical cut‐off for significance was set at false discovery rate (FDR) &lt; 0.01. For the murine study, unpaired analysis was conducted to compare each vaccine group with a group of PBS‐immunised mice, and the statistical cut‐off for significance was set at FDR &lt; 0.01.</p>
                </sec>
                <sec id="msb20209888-sec-0026">
                  <title>Cell enumeration whole blood transcriptomic data</title>
                  <p>Cell composition of infant whole blood samples was evaluated using the CIBERSORTx method (Newman <italic>et al</italic>, <xref rid="msb20209888-bib-0056" ref-type="ref">2019</xref>). A filtered (as described above), non‐log space reads per kilobase million (RKPMs) sample gene matrix and a “signature” gene files (LM22; 22 immune cell types and immunoStates; 20 immune cell types (Vallania <italic>et al</italic>, <xref rid="msb20209888-bib-0088" ref-type="ref">2018</xref>)) were used to deconvolute cell abundances. CIBERSORTx was run in relative mode, with B‐mode batch correction with 1,000 permutations, using cell type‐specific gene expression profiles for the analysis (Newman <italic>et al</italic>, <xref rid="msb20209888-bib-0056" ref-type="ref">2019</xref>). Cell composition of mouse samples was evaluated using the ImmQuant tool (Frishberg <italic>et al</italic>, <xref rid="msb20209888-bib-0024" ref-type="ref">2016</xref>). A filtered (as described above), log<sub>2</sub> transformed sample gene matrix and an Immunological Genome Project mouse gene expression dataset were used to infer immune cells based on signature markers (Heng <italic>et al</italic>, <xref rid="msb20209888-bib-0033" ref-type="ref">2008</xref>). Predicted relative abundances were calculated relative to the PBS‐immunised mouse samples.</p>
                </sec>
                <sec id="msb20209888-sec-0027">
                  <title>Pathway and gene set enrichment analysis</title>
                  <p>Gene set enrichment analysis was performed on differentially expressed genes (FDR &lt; 0.01) employing XGR, using the functional categories of Gene Ontologies (GO; biological process, cellular component and molecular function) (Fang <italic>et al</italic>, <xref rid="msb20209888-bib-0023" ref-type="ref">2016</xref>; The Gene Ontology Consortium, <xref rid="msb20209888-bib-0082" ref-type="ref">2017</xref>).</p>
                </sec>
                <sec id="msb20209888-sec-0028">
                  <title>Blood transcriptional modules</title>
                  <p>Blood transcriptional module analysis was undertaken using the “tmod” R package on genes ranked by their log‐ratio (LR) value; statistical testing for module expression was evaluated using the “tmodCERNOtest” function, which is a non‐parametric test working on gene ranks (Yamaguchi <italic>et al</italic>, <xref rid="msb20209888-bib-0101" ref-type="ref">2008</xref>; Weiner, <xref rid="msb20209888-bib-0096" ref-type="ref">2016</xref>).</p>
                </sec>
                <sec id="msb20209888-sec-0029">
                  <title>Machine learning</title>
                  <p>To identify baseline transcriptome predictors that can discriminate between infants that develop fever following 4CMenB vaccination, we applied sequential, iterative modelling “overnight”, SIMON, as described previously (preprint: Tomic <italic>et al</italic>, <xref rid="msb20209888-bib-0084" ref-type="ref">2019</xref>). Briefly, in the first step of the SIMON analysis, all data are centred and scaled; then, the dataset is divided into training (75%) and test sets (25%). The same training and test sets are used to evaluate the performance for each of the 215 algorithms tested and to select the best performing models. To evaluate model performance and test the validity of class predictors, we implemented the two‐step procedure in SIMON. The accuracy of the predictors was first tested by 10‐fold cross‐validation on 75% of the data from the initial dataset (training set only). The cross‐validation process is repeated five times, and cumulative error rate is calculated. To prevent optimistic accuracy estimates resulting from overfitting, in the last step, each model is evaluated on the withheld test set (Kohavi, <xref rid="msb20209888-bib-0041" ref-type="ref">1995</xref>). The performance of classification models was determined by calculating the area under the receiver operating characteristic curve (AUROC) for training (train AUROC) and test set (test AUROC). Out of all 215 algorithms tested, only 33 algorithms (15%) successfully built models, and only 10 models had good performance (training AUROC value above 0.7; Dataset <xref rid="msb20209888-sup-0014" ref-type="supplementary-material">EV13</xref>). Three of these models were overfitted, having AUROC value &lt; 0.7 as evaluated on the test set. In the final step, SIMON calculated the contribution of each feature to the model as variable importance score (scaled to maximum value of 100), as described in the R package “caret” (Kuhn, <xref rid="msb20209888-bib-0043" ref-type="ref">2017</xref>). Since variable importance score for each feature is determined by using the model information, this ultimately incorporates the correlation structure between the predictors and the importance calculation.</p>
                  <p>Similarly, a supervised machine learning algorithm was used to determine a predictive model of quantitative post‐vaccination (1 month after 4CMenB 4 months immunisation) MenB SBA titres based on pre‐vaccination gene expression profiles. For this purpose, we utilised a radial basis function kernel support vector regression (SVR), a support vector machine (SVM) that is appropriate for regression analysis (Smola &amp; Schölkopf, <xref rid="msb20209888-bib-0075" ref-type="ref">2004</xref>). Again, a partition was created with 75 and 25% of pre‐vaccination (test group only) RNA‐sequencing data in a training dataset and test dataset, respectively. Highly correlated genes (<italic>R</italic> &gt; 0.9) within the training dataset were removed from both datasets, which were then scaled and centred. SVR was used to tune model parameters, using 25 bootstrapped iterations of the training dataset with log<sub>10</sub> MenB SBA titres as the outcome measure, utilising the R package “caret” (Kuhn, <xref rid="msb20209888-bib-0043" ref-type="ref">2017</xref>). The summary metric used to select the optimal model was the root‐mean‐square error (RMSE). The final model from the training set was then used to assess its ability to predict log<sub>10</sub> MenB SBA titres in the test dataset.</p>
                </sec>
              </sec>
            </sec>
            <sec id="msb20209888-sec-0031">
              <title>Author contribution</title>
              <p>DO'C, ML and AJP conceptualised the project. DO'C, MVP, HR, SK, EP, MDS and AJP designed and/or managed the clinical trial. DS, CD, MS and CSR designed the mouse model study. DO'C, MVP, DS, RED, SC‐W, HH and LS conducted experimental procedures included within this report. DO'C, AT and UG completed the formal analysis. ML and AJP acquired the funding for this project. All authors reviewed and approved the manuscript.</p>
            </sec>
            <sec sec-type="COI-statement" id="msb20209888-sec-0032">
              <title>Conflict of interest</title>
              <p>AJP reports grants from Okairos outside the submitted work, and AJP is Chair of UK Department of Health and Social Care's Joint Committee on Vaccination and Immunisation, and the EMA scientific advisory group on vaccines and is a member of the World Health Organisation's Strategic Advisory Group of Experts on Immunisation. MDS acts as a Chief/Principal Investigator on clinical trials funded by vaccine manufacturers including Glaxosmithkline, Novavax, Medimmune, MCM, Pfizer and Janssen. These studies are conducted on behalf of the University of Oxford and MDS receives no personal financial benefit. MVP is a member of the Portuguese National Immunisation Technical Advisory Group (Comissão Técnica de Vacinação da Direcção Geral de Saúde).</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data"/>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0001">
                <caption>
                  <p>Appendix</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0002">
                <caption>
                  <p>Dataset EV1</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s002.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0003">
                <caption>
                  <p>Dataset EV2</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s003.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0004">
                <caption>
                  <p>Dataset EV3</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s004.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0005">
                <caption>
                  <p>Dataset EV4</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s005.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0006">
                <caption>
                  <p>Dataset EV5</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s006.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0007">
                <caption>
                  <p>Dataset EV6</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s007.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0008">
                <caption>
                  <p>Dataset EV7</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s008.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0009">
                <caption>
                  <p>Dataset EV8</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s009.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0010">
                <caption>
                  <p>Dataset EV9</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s010.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0011">
                <caption>
                  <p>Dataset EV10</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s011.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0012">
                <caption>
                  <p>Dataset EV11</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s012.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0013">
                <caption>
                  <p>Dataset EV12</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s013.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0014">
                <caption>
                  <p>Dataset EV13</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s014.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0015">
                <caption>
                  <p>Dataset EV14</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s015.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0016">
                <caption>
                  <p>Dataset EV15</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s016.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="msb20209888-sup-0017">
                <caption>
                  <p>Dataset EV16</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s017.xlsx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data">
                <caption>
                  <p>Review Process File</p>
                </caption>
                <media xlink:href="MSB-16-e9888-s018.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="msb20209888-sec-0030">
              <title>Acknowledgements</title>
              <p>This work received funding from the European Union's Seventh Framework Programme under EC‐GA no. 279185 (EUCLIDS) and Medical Research Council (MRC, UK). The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Funding for this study was also provided by GlaxoSmithKline Biologicals SA [NCT02080559]. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. CR is a Jenner Investigator, and is supported by the Oxford NIHR Biomedical Research Centre (BRC), Vaccine theme. We thank all the children and families who participated in the study, as well as the research nurses and doctors and laboratory scientists of Oxford Vaccine Group (University of Oxford, Oxford, UK). We also thank the High‐Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z) for the generation of the Sequencing data.</p>
            </ack>
            <sec sec-type="data-availability" id="msb20209888-sec-0034">
              <title>Data availability</title>
              <p>The human study and mouse datasets generated are available in the Gene Expression Omnibus (GSE131929 and GSE132199; <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>).</p>
            </sec>
            <ref-list content-type="cited-references" id="msb20209888-bibl-0001">
              <title>References</title>
              <ref id="msb20209888-bib-0001">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0001"><string-name><surname>Andrews</surname><given-names>N</given-names></string-name>, <string-name><surname>Borrow</surname><given-names>R</given-names></string-name>, <string-name><surname>Miller</surname><given-names>E</given-names></string-name> (<year>2003</year>) <article-title>Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England</article-title>. <source xml:lang="en">Clin Diagn Lab Immunol</source>
<volume>10</volume>: <fpage>780</fpage>–<lpage>786</lpage>
<pub-id pub-id-type="pmid">12965904</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0002">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0002"><string-name><surname>Andrews</surname><given-names>NJ</given-names></string-name>, <string-name><surname>Walker</surname><given-names>WT</given-names></string-name>, <string-name><surname>Finn</surname><given-names>A</given-names></string-name>, <string-name><surname>Heath</surname><given-names>PT</given-names></string-name>, <string-name><surname>Collinson</surname><given-names>AC</given-names></string-name>, <string-name><surname>Pollard</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Snape</surname><given-names>MD</given-names></string-name>, <string-name><surname>Faust</surname><given-names>SN</given-names></string-name>, <string-name><surname>Waight</surname><given-names>PA</given-names></string-name>, <string-name><surname>Hoschler</surname><given-names>K</given-names></string-name><italic>et al</italic> (<year>2011</year>) <article-title>Predictors of immune response and reactogenicity to AS03B‐adjuvanted split virion and non‐adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines</article-title>. <source xml:lang="en">Vaccine</source>
<volume>29</volume>: <fpage>7913</fpage>–<lpage>7919</lpage>
<pub-id pub-id-type="pmid">21875635</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0003">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0003"><string-name><surname>Anderson</surname><given-names>ST</given-names></string-name>, <string-name><surname>Kaforou</surname><given-names>M</given-names></string-name>, <string-name><surname>Brent</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Wright</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Banwell</surname><given-names>CM</given-names></string-name>, <string-name><surname>Chagaluka</surname><given-names>G</given-names></string-name>, <string-name><surname>Crampin</surname><given-names>AC</given-names></string-name>, <string-name><surname>Dockrell</surname><given-names>HM</given-names></string-name>, <string-name><surname>French</surname><given-names>N</given-names></string-name>, <string-name><surname>Hamilton</surname><given-names>MS</given-names></string-name><italic>et al</italic> (<year>2014</year>) <article-title>Diagnosis of childhood tuberculosis and host RNA expression in Africa</article-title>. <source xml:lang="en">N Engl J Med</source>
<volume>370</volume>: <fpage>1712</fpage>–<lpage>1723</lpage>
<pub-id pub-id-type="pmid">24785206</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0004">
                <mixed-citation publication-type="book" id="msb20209888-cit-0004"><string-name><surname>Bellman</surname><given-names>RE</given-names></string-name> (<year>1957</year>) <source xml:lang="en">Dynamic programming</source>. <publisher-name>Princeton University Press</publisher-name>, <publisher-loc>New York, NY</publisher-loc>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0005">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0005"><string-name><surname>Bendall</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Bradstock</surname><given-names>KF</given-names></string-name> (<year>2014</year>) <article-title>G‐CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent</article-title>. <source xml:lang="en">Cytokine Growth Factor Rev</source>
<volume>25</volume>: <fpage>355</fpage>–<lpage>367</lpage>
<pub-id pub-id-type="pmid">25131807</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0006">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0006"><string-name><surname>Blohmke</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Darton</surname><given-names>TC</given-names></string-name>, <string-name><surname>Jones</surname><given-names>C</given-names></string-name>, <string-name><surname>Suarez</surname><given-names>NM</given-names></string-name>, <string-name><surname>Waddington</surname><given-names>CS</given-names></string-name>, <string-name><surname>Angus</surname><given-names>B</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name><surname>Hill</surname><given-names>J</given-names></string-name>, <string-name><surname>Clare</surname><given-names>S</given-names></string-name>, <string-name><surname>Kane</surname><given-names>L</given-names></string-name><italic>et al</italic> (<year>2016</year>) <article-title>Interferon‐driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid fever</article-title>. <source xml:lang="en">J Exp Med</source>
<volume>213</volume>: <fpage>1061</fpage>–<lpage>1077</lpage>
<pub-id pub-id-type="pmid">27217537</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0007">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0007"><string-name><surname>Bommert</surname><given-names>A</given-names></string-name>, <string-name><surname>Sun</surname><given-names>X</given-names></string-name>, <string-name><surname>Bischl</surname><given-names>B</given-names></string-name>, <string-name><surname>Rahnenführer</surname><given-names>J</given-names></string-name>, <string-name><surname>Lang</surname><given-names>M</given-names></string-name> (<year>2020</year>) <article-title>Benchmark for filter methods for feature selection in high‐dimensional classification data</article-title>. <source xml:lang="en">Comput Stat Data Anal</source>
<volume>143</volume>: <elocation-id>106839</elocation-id>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0008">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0008"><string-name><surname>Borrow</surname><given-names>R</given-names></string-name>, <string-name><surname>Aaberge</surname><given-names>IS</given-names></string-name>, <string-name><surname>Santos</surname><given-names>GF</given-names></string-name>, <string-name><surname>Eudey</surname><given-names>TL</given-names></string-name>, <string-name><surname>Oster</surname><given-names>P</given-names></string-name>, <string-name><surname>Glennie</surname><given-names>A</given-names></string-name>, <string-name><surname>Findlow</surname><given-names>J</given-names></string-name>, <string-name><surname>Høiby</surname><given-names>EA</given-names></string-name>, <string-name><surname>Rosenqvist</surname><given-names>E</given-names></string-name>, <string-name><surname>Balmer</surname><given-names>P</given-names></string-name><italic>et al</italic> (<year>2005</year>) <article-title>Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76‐SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine</article-title>. <source xml:lang="en">Clin Diagn Lab Immunol</source>
<volume>12</volume>: <fpage>970</fpage>–<lpage>976</lpage>
<pub-id pub-id-type="pmid">16085915</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0009">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0009"><string-name><surname>Bouchon</surname><given-names>A</given-names></string-name>, <string-name><surname>Facchetti</surname><given-names>F</given-names></string-name>, <string-name><surname>Weigand</surname><given-names>MA</given-names></string-name>, <string-name><surname>Colonna</surname><given-names>M</given-names></string-name> (<year>2001</year>) <article-title>TREM‐1 amplifies inflammation and is a crucial mediator of septic shock</article-title>. <source xml:lang="en">Nature</source>
<volume>410</volume>: <fpage>1103</fpage>–<lpage>1107</lpage>
<pub-id pub-id-type="pmid">11323674</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0010">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0010"><string-name><surname>Calabro</surname><given-names>S</given-names></string-name>, <string-name><surname>Tortoli</surname><given-names>M</given-names></string-name>, <string-name><surname>Baudner</surname><given-names>BC</given-names></string-name>, <string-name><surname>Pacitto</surname><given-names>A</given-names></string-name>, <string-name><surname>Cortese</surname><given-names>M</given-names></string-name>, <string-name><surname>O'Hagan</surname><given-names>DT</given-names></string-name>, <string-name><surname>De Gregorio</surname><given-names>E</given-names></string-name>, <string-name><surname>Seubert</surname><given-names>A</given-names></string-name>, <string-name><surname>Wack</surname><given-names>A</given-names></string-name> (<year>2011</year>) <article-title>Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes</article-title>. <source xml:lang="en">Vaccine</source>
<volume>29</volume>: <fpage>1812</fpage>–<lpage>1823</lpage>
<pub-id pub-id-type="pmid">21215831</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0011">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0011"><string-name><surname>Capitano</surname><given-names>ML</given-names></string-name>, <string-name><surname>Nemeth</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Mace</surname><given-names>TA</given-names></string-name>, <string-name><surname>Salisbury‐Ruf</surname><given-names>C</given-names></string-name>, <string-name><surname>Segal</surname><given-names>BH</given-names></string-name>, <string-name><surname>McCarthy</surname><given-names>PL</given-names></string-name>, <string-name><surname>Repasky</surname><given-names>EA</given-names></string-name> (<year>2012</year>) <article-title>Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL‐1‐, IL‐17‐, and G‐CSF‐dependent manner</article-title>. <source xml:lang="en">Blood</source>
<volume>120</volume>: <fpage>2600</fpage>–<lpage>2609</lpage>
<pub-id pub-id-type="pmid">22806894</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0012">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0012"><string-name><surname>Cepika</surname><given-names>AM</given-names></string-name>, <string-name><surname>Banchereau</surname><given-names>R</given-names></string-name>, <string-name><surname>Segura</surname><given-names>E</given-names></string-name>, <string-name><surname>Ohouo</surname><given-names>M</given-names></string-name>, <string-name><surname>Cantarel</surname><given-names>B</given-names></string-name>, <string-name><surname>Goller</surname><given-names>K</given-names></string-name>, <string-name><surname>Cantrell</surname><given-names>V</given-names></string-name>, <string-name><surname>Ruchaud</surname><given-names>E</given-names></string-name>, <string-name><surname>Gatewood</surname><given-names>E</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>P</given-names></string-name><italic>et al</italic> (<year>2017</year>) <article-title>A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis</article-title>. <source xml:lang="en">J Exp Med</source>
<volume>214</volume>: <fpage>3449</fpage>–<lpage>3466</lpage>
<pub-id pub-id-type="pmid">28935693</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0013">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0013"><string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Corriden</surname><given-names>R</given-names></string-name>, <string-name><surname>Inoue</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yip</surname><given-names>L</given-names></string-name>, <string-name><surname>Hashiguchi</surname><given-names>N</given-names></string-name>, <string-name><surname>Zinkernagel</surname><given-names>A</given-names></string-name>, <string-name><surname>Nizet</surname><given-names>V</given-names></string-name>, <string-name><surname>Insel</surname><given-names>PA</given-names></string-name>, <string-name><surname>Junger</surname><given-names>WG</given-names></string-name> (<year>2006</year>) <article-title>ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors</article-title>. <source xml:lang="en">Science</source>
<volume>314</volume>: <fpage>1792</fpage>–<lpage>1795</lpage>
<pub-id pub-id-type="pmid">17170310</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0014">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0014"><string-name><surname>Craig</surname><given-names>JC</given-names></string-name>, <string-name><surname>Williams</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Jones</surname><given-names>M</given-names></string-name>, <string-name><surname>Codarini</surname><given-names>M</given-names></string-name>, <string-name><surname>Macaskill</surname><given-names>P</given-names></string-name>, <string-name><surname>Hayen</surname><given-names>A</given-names></string-name>, <string-name><surname>Irwig</surname><given-names>L</given-names></string-name>, <string-name><surname>Fitzgerald</surname><given-names>DA</given-names></string-name>, <string-name><surname>Isaacs</surname><given-names>D</given-names></string-name>, <string-name><surname>McCaskill</surname><given-names>M</given-names></string-name> (<year>2010</year>) <article-title>The accuracy of clinical symptoms and signs for the diagnosis of serious bacterial infection in young febrile children: prospective cohort study of 15 781 febrile illnesses</article-title>. <source xml:lang="en">BMJ</source>
<volume>340</volume>: <elocation-id>c1594</elocation-id>
<pub-id pub-id-type="pmid">20406860</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0015">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0015"><string-name><surname>Davenport</surname><given-names>EE</given-names></string-name>, <string-name><surname>Burnham</surname><given-names>KL</given-names></string-name>, <string-name><surname>Radhakrishnan</surname><given-names>J</given-names></string-name>, <string-name><surname>Humburg</surname><given-names>P</given-names></string-name>, <string-name><surname>Hutton</surname><given-names>P</given-names></string-name>, <string-name><surname>Mills</surname><given-names>TC</given-names></string-name>, <string-name><surname>Rautanen</surname><given-names>A</given-names></string-name>, <string-name><surname>Gordon</surname><given-names>AC</given-names></string-name>, <string-name><surname>Garrard</surname><given-names>C</given-names></string-name>, <string-name><surname>Hill</surname><given-names>AV</given-names></string-name><italic>et al</italic> (<year>2016</year>) <article-title>Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study</article-title>. <source xml:lang="en">Lancet Respir Med</source>
<volume>4</volume>: <fpage>259</fpage>–<lpage>271</lpage>
<pub-id pub-id-type="pmid">26917434</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0016">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0016"><string-name><surname>Dobin</surname><given-names>A</given-names></string-name>, <string-name><surname>Davis</surname><given-names>CA</given-names></string-name>, <string-name><surname>Schlesinger</surname><given-names>F</given-names></string-name>, <string-name><surname>Drenkow</surname><given-names>J</given-names></string-name>, <string-name><surname>Zaleski</surname><given-names>C</given-names></string-name>, <string-name><surname>Jha</surname><given-names>S</given-names></string-name>, <string-name><surname>Batut</surname><given-names>P</given-names></string-name>, <string-name><surname>Chaisson</surname><given-names>M</given-names></string-name>, <string-name><surname>Gingeras</surname><given-names>TR</given-names></string-name> (<year>2013</year>) <article-title>STAR: ultrafast universal RNA‐seq aligner</article-title>. <source xml:lang="en">Bioinformatics</source>
<volume>29</volume>: <fpage>15</fpage>–<lpage>21</lpage>
<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0017">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0017"><string-name><surname>Dowling</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Sanders</surname><given-names>H</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>WK</given-names></string-name>, <string-name><surname>Joshi</surname><given-names>S</given-names></string-name>, <string-name><surname>Brightman</surname><given-names>S</given-names></string-name>, <string-name><surname>Bergelson</surname><given-names>I</given-names></string-name>, <string-name><surname>Pietrasanta</surname><given-names>C</given-names></string-name>, <string-name><surname>van Haren</surname><given-names>SD</given-names></string-name>, <string-name><surname>van Amsterdam</surname><given-names>S</given-names></string-name>, <string-name><surname>Fernandez</surname><given-names>J</given-names></string-name><italic>et al</italic> (<year>2016</year>) <article-title>A meningococcal outer membrane vesicle vaccine incorporating genetically attenuated endotoxin dissociates inflammation from immunogenicity</article-title>. <source xml:lang="en">Front Immunol</source>
<volume>7</volume>: <fpage>562</fpage>
<pub-id pub-id-type="pmid">28008331</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0018">
                <mixed-citation publication-type="book" id="msb20209888-cit-0018"><collab collab-type="authors">ECDC</collab>
(<year>2018</year>) <source xml:lang="en"><italic toggle="yes">European centre for disease prevention and control: European vaccination programmes</italic></source>.</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0019">
                <mixed-citation publication-type="miscellaneous" id="msb20209888-cit-0019"><collab collab-type="authors">ECDC ECfDPaC</collab>
(<year>2017</year>) <article-title>European Centre for Disease Prevention and Control. Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA</article-title>.</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0020">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0020"><string-name><surname>Esposito</surname><given-names>S</given-names></string-name>, <string-name><surname>Prymula</surname><given-names>R</given-names></string-name>, <string-name><surname>Zuccotti</surname><given-names>GV</given-names></string-name>, <string-name><surname>Xie</surname><given-names>F</given-names></string-name>, <string-name><surname>Barone</surname><given-names>M</given-names></string-name>, <string-name><surname>Dull</surname><given-names>PM</given-names></string-name>, <string-name><surname>Toneatto</surname><given-names>D</given-names></string-name> (<year>2014</year>) <article-title>A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II)</article-title>. <source xml:lang="en">Hum Vaccin Immunother</source>
<volume>10</volume>: <fpage>2005</fpage>–<lpage>2014</lpage>
<pub-id pub-id-type="pmid">25424810</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0021">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0021"><string-name><surname>Evans</surname><given-names>SS</given-names></string-name>, <string-name><surname>Repasky</surname><given-names>EA</given-names></string-name>, <string-name><surname>Fisher</surname><given-names>DT</given-names></string-name> (<year>2015</year>) <article-title>Fever and the thermal regulation of immunity: the immune system feels the heat</article-title>. <source xml:lang="en">Nat Rev Immunol</source>
<volume>15</volume>: <fpage>335</fpage>–<lpage>349</lpage>
<pub-id pub-id-type="pmid">25976513</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0022">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0022"><string-name><surname>Faix</surname><given-names>JD</given-names></string-name> (<year>2013</year>) <article-title>Biomarkers of sepsis</article-title>. <source xml:lang="en">Crit Rev Clin Lab Sci</source>
<volume>50</volume>: <fpage>23</fpage>–<lpage>36</lpage>
<pub-id pub-id-type="pmid">23480440</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0023">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0023"><string-name><surname>Fang</surname><given-names>H</given-names></string-name>, <string-name><surname>Knezevic</surname><given-names>B</given-names></string-name>, <string-name><surname>Burnham</surname><given-names>KL</given-names></string-name>, <string-name><surname>Knight</surname><given-names>JC</given-names></string-name> (<year>2016</year>) <article-title>XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits</article-title>. <source xml:lang="en">Genome Med</source>
<volume>8</volume>: <fpage>129</fpage>
<pub-id pub-id-type="pmid">27964755</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0024">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0024"><string-name><surname>Frishberg</surname><given-names>A</given-names></string-name>, <string-name><surname>Brodt</surname><given-names>A</given-names></string-name>, <string-name><surname>Steuerman</surname><given-names>Y</given-names></string-name>, <string-name><surname>Gat‐Viks</surname><given-names>I</given-names></string-name> (<year>2016</year>) <article-title>ImmQuant: a user‐friendly tool for inferring immune cell‐type composition from gene‐expression data</article-title>. <source xml:lang="en">Bioinformatics</source>
<volume>32</volume>: <fpage>3842</fpage>–<lpage>3843</lpage>
<pub-id pub-id-type="pmid">27531105</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0025">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0025"><string-name><surname>Fuller</surname><given-names>CL</given-names></string-name>, <string-name><surname>Brittingham</surname><given-names>KC</given-names></string-name>, <string-name><surname>Porter</surname><given-names>MW</given-names></string-name>, <string-name><surname>Hepburn</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Petitt</surname><given-names>PL</given-names></string-name>, <string-name><surname>Pittman</surname><given-names>PR</given-names></string-name>, <string-name><surname>Bavari</surname><given-names>S</given-names></string-name> (<year>2007</year>) <article-title>Transcriptome analysis of human immune responses following live vaccine strain (LVS) <italic>Francisella tularensis</italic> vaccination</article-title>. <source xml:lang="en">Mol Immunol</source>
<volume>44</volume>: <fpage>3173</fpage>–<lpage>3184</lpage>
<pub-id pub-id-type="pmid">17349694</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0026">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0026"><string-name><surname>Garlanda</surname><given-names>C</given-names></string-name>, <string-name><surname>Dinarello</surname><given-names>CA</given-names></string-name>, <string-name><surname>Mantovani</surname><given-names>A</given-names></string-name> (<year>2013</year>) <article-title>The interleukin‐1 family: back to the future</article-title>. <source xml:lang="en">Immunity</source>
<volume>39</volume>: <fpage>1003</fpage>–<lpage>1018</lpage>
<pub-id pub-id-type="pmid">24332029</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0027">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0027"><string-name><surname>Goldschneider</surname><given-names>I</given-names></string-name>, <string-name><surname>Gotschlich</surname><given-names>E</given-names></string-name>, <string-name><surname>Artenstein</surname><given-names>M</given-names></string-name> (<year>1969</year>) <article-title>Human immunity to the meningococcus. I. The role of humoral antibodies</article-title>. <source xml:lang="en">J Exp Med</source>
<volume>129</volume>: <fpage>1307</fpage>–<lpage>1326</lpage>
<pub-id pub-id-type="pmid">4977280</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0028">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0028"><string-name><surname>Golub</surname><given-names>TR</given-names></string-name>, <string-name><surname>Slonim</surname><given-names>DK</given-names></string-name>, <string-name><surname>Tamayo</surname><given-names>P</given-names></string-name>, <string-name><surname>Huard</surname><given-names>C</given-names></string-name>, <string-name><surname>Gaasenbeek</surname><given-names>M</given-names></string-name>, <string-name><surname>Mesirov</surname><given-names>JP</given-names></string-name>, <string-name><surname>Coller</surname><given-names>H</given-names></string-name>, <string-name><surname>Loh</surname><given-names>ML</given-names></string-name>, <string-name><surname>Downing</surname><given-names>JR</given-names></string-name>, <string-name><surname>Caligiuri</surname><given-names>MA</given-names></string-name><italic>et al</italic> (<year>1999</year>) <article-title>Molecular classification of cancer: class discovery and class prediction by gene expression monitoring</article-title>. <source xml:lang="en">Science</source>
<volume>286</volume>: <fpage>531</fpage>–<lpage>537</lpage>
<pub-id pub-id-type="pmid">10521349</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0029">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0029"><string-name><surname>Gossger</surname><given-names>N</given-names></string-name>, <string-name><surname>Snape</surname><given-names>MD</given-names></string-name>, <string-name><surname>Yu</surname><given-names>LM</given-names></string-name>, <string-name><surname>Finn</surname><given-names>A</given-names></string-name>, <string-name><surname>Bona</surname><given-names>G</given-names></string-name>, <string-name><surname>Esposito</surname><given-names>S</given-names></string-name>, <string-name><surname>Principi</surname><given-names>N</given-names></string-name>, <string-name><surname>Diez‐Domingo</surname><given-names>J</given-names></string-name>, <string-name><surname>Sokal</surname><given-names>E</given-names></string-name>, <string-name><surname>Becker</surname><given-names>B</given-names></string-name><italic>et al</italic> (<year>2012</year>) <article-title>Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial</article-title>. <source xml:lang="en">JAMA</source>
<volume>307</volume>: <fpage>573</fpage>–<lpage>582</lpage>
<pub-id pub-id-type="pmid">22318278</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0030">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0030"><string-name><surname>Hara</surname><given-names>T</given-names></string-name>, <string-name><surname>Mimura</surname><given-names>K</given-names></string-name>, <string-name><surname>Abe</surname><given-names>T</given-names></string-name>, <string-name><surname>Shioi</surname><given-names>G</given-names></string-name>, <string-name><surname>Seiki</surname><given-names>M</given-names></string-name>, <string-name><surname>Sakamoto</surname><given-names>T</given-names></string-name> (<year>2011</year>) <article-title>Deletion of the Mint3/Apba3 gene in mice abrogates macrophage functions and increases resistance to lipopolysaccharide‐induced septic shock</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>286</volume>: <fpage>32542</fpage>–<lpage>32551</lpage>
<pub-id pub-id-type="pmid">21778228</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0031">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0031"><string-name><surname>Heinrich</surname><given-names>PC</given-names></string-name>, <string-name><surname>Castell</surname><given-names>JV</given-names></string-name>, <string-name><surname>Andus</surname><given-names>T</given-names></string-name> (<year>1990</year>) <article-title>Interleukin‐6 and the acute phase response</article-title>. <source xml:lang="en">Biochem J</source>
<volume>265</volume>: <fpage>621</fpage>–<lpage>636</lpage>
<pub-id pub-id-type="pmid">1689567</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0032">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0032"><string-name><surname>Hemingway</surname><given-names>C</given-names></string-name>, <string-name><surname>Berk</surname><given-names>M</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>ST</given-names></string-name>, <string-name><surname>Wright</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Hamilton</surname><given-names>S</given-names></string-name>, <string-name><surname>Eleftherohorinou</surname><given-names>H</given-names></string-name>, <string-name><surname>Kaforou</surname><given-names>M</given-names></string-name>, <string-name><surname>Goldgof</surname><given-names>GM</given-names></string-name>, <string-name><surname>Hickman</surname><given-names>K</given-names></string-name>, <string-name><surname>Kampmann</surname><given-names>B</given-names></string-name><italic>et al</italic> (<year>2017</year>) <article-title>Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function</article-title>. <source xml:lang="en">PLoS One</source>
<volume>12</volume>: <elocation-id>e0185973</elocation-id>
<pub-id pub-id-type="pmid">29140996</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0033">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0033"><string-name><surname>Heng</surname><given-names>TSP</given-names></string-name>, <string-name><surname>Painter</surname><given-names>MW</given-names></string-name>, <collab collab-type="authors">Consortium IGP</collab>
(<year>2008</year>) <article-title>The Immunological Genome Project: networks of gene expression in immune cells</article-title>. <source xml:lang="en">Nat Immunol</source>
<volume>9</volume>: <fpage>1091</fpage>–<lpage>1094</lpage>
<pub-id pub-id-type="pmid">18800157</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0034">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0034"><string-name><surname>Herberg</surname><given-names>JA</given-names></string-name>, <string-name><surname>Kaforou</surname><given-names>M</given-names></string-name>, <string-name><surname>Wright</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Shailes</surname><given-names>H</given-names></string-name>, <string-name><surname>Eleftherohorinou</surname><given-names>H</given-names></string-name>, <string-name><surname>Hoggart</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Cebey‐López</surname><given-names>M</given-names></string-name>, <string-name><surname>Carter</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Janes</surname><given-names>VA</given-names></string-name>, <string-name><surname>Gormley</surname><given-names>S</given-names></string-name><italic>et al</italic> (<year>2016</year>) <article-title>Diagnostic test accuracy of a 2‐transcript host RNA signature for discriminating bacterial vs viral infection in febrile children</article-title>. <source xml:lang="en">JAMA</source>
<volume>316</volume>: <fpage>835</fpage>–<lpage>845</lpage>
<pub-id pub-id-type="pmid">27552617</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0035">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0035"><string-name><surname>Irwin</surname><given-names>AD</given-names></string-name>, <string-name><surname>Grant</surname><given-names>A</given-names></string-name>, <string-name><surname>Williams</surname><given-names>R</given-names></string-name>, <string-name><surname>Kolamunnage‐Dona</surname><given-names>R</given-names></string-name>, <string-name><surname>Drew</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Paulus</surname><given-names>S</given-names></string-name>, <string-name><surname>Jeffers</surname><given-names>G</given-names></string-name>, <string-name><surname>Williams</surname><given-names>K</given-names></string-name>, <string-name><surname>Breen</surname><given-names>R</given-names></string-name>, <string-name><surname>Preston</surname><given-names>J</given-names></string-name><italic>et al</italic> (<year>2017</year>) <article-title>Predicting risk of serious bacterial infections in febrile children in the emergency department</article-title>. <source xml:lang="en">Pediatrics</source>
<volume>140</volume>: <fpage>e20162853</fpage>
<pub-id pub-id-type="pmid">28679639</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0036">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0036"><string-name><surname>Jones</surname><given-names>SA</given-names></string-name>, <string-name><surname>Jenkins</surname><given-names>BJ</given-names></string-name> (<year>2018</year>) <article-title>Recent insights into targeting the IL‐6 cytokine family in inflammatory diseases and cancer</article-title>. <source xml:lang="en">Nat Rev Immunol</source>
<volume>18</volume>: <fpage>773</fpage>–<lpage>789</lpage>
<pub-id pub-id-type="pmid">30254251</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0037">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0037"><string-name><surname>Kaforou</surname><given-names>M</given-names></string-name>, <string-name><surname>Wright</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Oni</surname><given-names>T</given-names></string-name>, <string-name><surname>French</surname><given-names>N</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>ST</given-names></string-name>, <string-name><surname>Bangani</surname><given-names>N</given-names></string-name>, <string-name><surname>Banwell</surname><given-names>CM</given-names></string-name>, <string-name><surname>Brent</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Crampin</surname><given-names>AC</given-names></string-name>, <string-name><surname>Dockrell</surname><given-names>HM</given-names></string-name><italic>et al</italic> (<year>2013</year>) <article-title>Detection of tuberculosis in HIV‐infected and ‐uninfected African adults using whole blood RNA expression signatures: a case‐control study</article-title>. <source xml:lang="en">PLoS Med</source>
<volume>10</volume>: <elocation-id>e1001538</elocation-id>
<pub-id pub-id-type="pmid">24167453</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0038">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0038"><string-name><surname>Kapur</surname><given-names>S</given-names></string-name>, <string-name><surname>Bourke</surname><given-names>T</given-names></string-name>, <string-name><surname>Maney</surname><given-names>JA</given-names></string-name>, <string-name><surname>Moriarty</surname><given-names>P</given-names></string-name> (<year>2017</year>) <article-title>Emergency department attendance following 4‐component meningococcal B vaccination in infants</article-title>. <source xml:lang="en">Arch Dis Child</source>
<volume>102</volume>: <fpage>899</fpage>–<lpage>902</lpage>
<pub-id pub-id-type="pmid">28637642</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0039">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0039"><string-name><surname>Kent</surname><given-names>A</given-names></string-name>, <string-name><surname>Beebeejaun</surname><given-names>K</given-names></string-name>, <string-name><surname>Braccio</surname><given-names>S</given-names></string-name>, <string-name><surname>Kadambari</surname><given-names>S</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>P</given-names></string-name>, <string-name><surname>Heath</surname><given-names>PT</given-names></string-name>, <string-name><surname>Ladhani</surname><given-names>S</given-names></string-name>, <string-name><surname>Network</surname><given-names>NNA</given-names></string-name> (<year>2019</year>) <article-title>Safety of meningococcal group B vaccination in hospitalised premature infants</article-title>. <source xml:lang="en">Arch Dis Child Fetal Neonatal Ed</source>
<volume>104</volume>: <fpage>F171</fpage>–<lpage>F175</lpage>
<pub-id pub-id-type="pmid">29636385</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0040">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0040"><string-name><surname>Kim</surname><given-names>VOPD</given-names></string-name>, <string-name><surname>Paggi</surname><given-names>JM</given-names></string-name>, <collab collab-type="authors">View ORCID Profile Salzberg S</collab>
(<year>2018</year>) <article-title>HISAT‐genotype: next generation genomic analysis platform on a personal computer</article-title>. <source xml:lang="en">Biorxiv</source>
<pub-id pub-id-type="doi">10.1101/266197</pub-id> [PREPRINT]</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0041">
                <mixed-citation publication-type="book" id="msb20209888-cit-0041"><string-name><surname>Kohavi</surname><given-names>R</given-names></string-name> (<year>1995</year>) <chapter-title>A study of cross‐validation and bootstrap for accuracy estimation and model selection</chapter-title> In <source xml:lang="en">Proceedings of the 14th International Joint Conference on Artificial Intelligence</source>, Vol. <volume>2</volume>, pp <fpage>1137</fpage>–<lpage>1143</lpage>. <publisher-loc>Montreal, QC</publisher-loc>: <publisher-name>Morgan Kaufmann Publishers Inc</publisher-name>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0042">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0042"><string-name><surname>Kohavi</surname><given-names>R</given-names></string-name>, <string-name><surname>John</surname><given-names>GH</given-names></string-name> (<year>1997</year>) <article-title>Wrappers for feature subset selection</article-title>. <source xml:lang="en">Relevance</source>
<volume>97</volume>: <fpage>273</fpage>–<lpage>324</lpage>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0043">
                <mixed-citation publication-type="book" id="msb20209888-cit-0043"><string-name><surname>Kuhn</surname><given-names>M</given-names></string-name> (<year>2017</year>) <article-title>caret: Classification and Regression Training</article-title>. <publisher-name>CRAN</publisher-name> v.6.0.80</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0044">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0044"><string-name><surname>Law</surname><given-names>CW</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Shi</surname><given-names>W</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name> (<year>2014</year>) <article-title>voom: Precision weights unlock linear model analysis tools for RNA‐seq read counts</article-title>. <source xml:lang="en">Genome Biol</source>
<volume>15</volume>: <fpage>R29</fpage>
<pub-id pub-id-type="pmid">24485249</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0045">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0045"><string-name><surname>Li‐Kim‐Moy</surname><given-names>J</given-names></string-name>, <string-name><surname>Wood</surname><given-names>N</given-names></string-name>, <string-name><surname>Jones</surname><given-names>C</given-names></string-name>, <string-name><surname>Macartney</surname><given-names>K</given-names></string-name>, <string-name><surname>Booy</surname><given-names>R</given-names></string-name> (<year>2018</year>) <article-title>Impact of fever and antipyretic use on influenza vaccine immune reponses in children</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>
<volume>37</volume>: <fpage>971</fpage>–<lpage>975</lpage>
<pub-id pub-id-type="pmid">29465480</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0046">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0046"><string-name><surname>Liu</surname><given-names>C</given-names></string-name>, <string-name><surname>Gelius</surname><given-names>E</given-names></string-name>, <string-name><surname>Liu</surname><given-names>G</given-names></string-name>, <string-name><surname>Steiner</surname><given-names>H</given-names></string-name>, <string-name><surname>Dziarski</surname><given-names>R</given-names></string-name> (<year>2000</year>) <article-title>Mammalian peptidoglycan recognition protein binds peptidoglycan with high affinity, is expressed in neutrophils, and inhibits bacterial growth</article-title>. <source xml:lang="en">J Biol Chem</source>
<volume>275</volume>: <fpage>24490</fpage>–<lpage>24499</lpage>
<pub-id pub-id-type="pmid">10827080</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0047">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0047"><string-name><surname>Mahajan</surname><given-names>P</given-names></string-name>, <string-name><surname>Kuppermann</surname><given-names>N</given-names></string-name>, <string-name><surname>Mejias</surname><given-names>A</given-names></string-name>, <string-name><surname>Suarez</surname><given-names>N</given-names></string-name>, <string-name><surname>Chaussabel</surname><given-names>D</given-names></string-name>, <string-name><surname>Casper</surname><given-names>TC</given-names></string-name>, <string-name><surname>Smith</surname><given-names>B</given-names></string-name>, <string-name><surname>Alpern</surname><given-names>ER</given-names></string-name>, <string-name><surname>Anders</surname><given-names>J</given-names></string-name>, <string-name><surname>Atabaki</surname><given-names>SM</given-names></string-name><italic>et al</italic> (<year>2016</year>) <article-title>Association of RNA biosignatures with bacterial infections in febrile infants aged 60 days or younger</article-title>. <source xml:lang="en">JAMA</source>
<volume>316</volume>: <fpage>846</fpage>–<lpage>857</lpage>
<pub-id pub-id-type="pmid">27552618</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0048">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0048"><string-name><surname>Mantovani</surname><given-names>A</given-names></string-name>, <string-name><surname>Cassatella</surname><given-names>MA</given-names></string-name>, <string-name><surname>Costantini</surname><given-names>C</given-names></string-name>, <string-name><surname>Jaillon</surname><given-names>S</given-names></string-name> (<year>2011</year>) <article-title>Neutrophils in the activation and regulation of innate and adaptive immunity</article-title>. <source xml:lang="en">Nat Rev Immunol</source>
<volume>11</volume>: <fpage>519</fpage>–<lpage>531</lpage>
<pub-id pub-id-type="pmid">21785456</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0049">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0049"><string-name><surname>Martinón‐Torres</surname><given-names>F</given-names></string-name>, <string-name><surname>Safadi</surname><given-names>MAP</given-names></string-name>, <string-name><surname>Martinez</surname><given-names>AC</given-names></string-name>, <string-name><surname>Marquez</surname><given-names>PI</given-names></string-name>, <string-name><surname>Torres</surname><given-names>JCT</given-names></string-name>, <string-name><surname>Weckx</surname><given-names>LY</given-names></string-name>, <string-name><surname>Moreira</surname><given-names>ED</given-names></string-name>, <string-name><surname>Mensi</surname><given-names>I</given-names></string-name>, <string-name><surname>Calabresi</surname><given-names>M</given-names></string-name>, <string-name><surname>Toneatto</surname><given-names>D</given-names></string-name> (<year>2017</year>) <article-title>Reduced schedules of 4CMenB vaccine in infants and catch‐up series in children: Immunogenicity and safety results from a randomised open‐label phase 3b trial</article-title>. <source xml:lang="en">Vaccine</source>
<volume>35</volume>: <fpage>3548</fpage>–<lpage>3557</lpage>
<pub-id pub-id-type="pmid">28533054</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0050">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0050"><string-name><surname>McCarthy</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name> (<year>2012</year>) <article-title>Differential expression analysis of multifactor RNA‐Seq experiments with respect to biological variation</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<volume>40</volume>: <fpage>4288</fpage>–<lpage>4297</lpage>
<pub-id pub-id-type="pmid">22287627</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0051">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0051"><string-name><surname>Murdoch</surname><given-names>H</given-names></string-name>, <string-name><surname>Wallace</surname><given-names>L</given-names></string-name>, <string-name><surname>Bishop</surname><given-names>J</given-names></string-name>, <string-name><surname>Robertson</surname><given-names>C</given-names></string-name>, <string-name><surname>Claire Cameron</surname><given-names>J</given-names></string-name> (<year>2017</year>) <article-title>Risk of hospitalisation with fever following MenB vaccination: self‐controlled case series analysis</article-title>. <source xml:lang="en">Arch Dis Child</source>
<volume>102</volume>: <fpage>894</fpage>–<lpage>898</lpage>
<pub-id pub-id-type="pmid">28931535</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0052">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0052"><string-name><surname>Nainani</surname><given-names>V</given-names></string-name>, <string-name><surname>Galal</surname><given-names>U</given-names></string-name>, <string-name><surname>Buttery</surname><given-names>J</given-names></string-name>, <string-name><surname>Snape</surname><given-names>MD</given-names></string-name> (<year>2017</year>) <article-title>An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study</article-title>. <source xml:lang="en">Arch Dis Child</source>
<volume>102</volume>: <fpage>958</fpage>–<lpage>962</lpage>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0053">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0053"><string-name><surname>Nakaya</surname><given-names>HI</given-names></string-name>, <string-name><surname>Hagan</surname><given-names>T</given-names></string-name>, <string-name><surname>Duraisingham</surname><given-names>SS</given-names></string-name>, <string-name><surname>Lee</surname><given-names>EK</given-names></string-name>, <string-name><surname>Kwissa</surname><given-names>M</given-names></string-name>, <string-name><surname>Rouphael</surname><given-names>N</given-names></string-name>, <string-name><surname>Frasca</surname><given-names>D</given-names></string-name>, <string-name><surname>Gersten</surname><given-names>M</given-names></string-name>, <string-name><surname>Mehta</surname><given-names>AK</given-names></string-name>, <string-name><surname>Gaujoux</surname><given-names>R</given-names></string-name><italic>et al</italic> (<year>2015</year>) <article-title>Systems analysis of immunity to influenza vaccination across multiple years and in diverse populations reveals shared molecular signatures</article-title>. <source xml:lang="en">Immunity</source>
<volume>43</volume>: <fpage>1186</fpage>–<lpage>1198</lpage>
<pub-id pub-id-type="pmid">26682988</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0054">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0054"><string-name><surname>Nakaya</surname><given-names>HI</given-names></string-name>, <string-name><surname>Clutterbuck</surname><given-names>E</given-names></string-name>, <string-name><surname>Kazmin</surname><given-names>D</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name><surname>Cortese</surname><given-names>M</given-names></string-name>, <string-name><surname>Bosinger</surname><given-names>SE</given-names></string-name>, <string-name><surname>Patel</surname><given-names>NB</given-names></string-name>, <string-name><surname>Zak</surname><given-names>DE</given-names></string-name>, <string-name><surname>Aderem</surname><given-names>A</given-names></string-name>, <string-name><surname>Dong</surname><given-names>T</given-names></string-name><italic>et al</italic> (<year>2016</year>) <article-title>Systems biology of immunity to MF59‐adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood</article-title>. <source xml:lang="en">Proc Natl Acad Sci USA</source>
<volume>113</volume>: <fpage>1853</fpage>–<lpage>1858</lpage>
<pub-id pub-id-type="pmid">26755593</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0055">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0055"><string-name><surname>Newman</surname><given-names>AM</given-names></string-name>, <string-name><surname>Liu</surname><given-names>CL</given-names></string-name>, <string-name><surname>Green</surname><given-names>MR</given-names></string-name>, <string-name><surname>Gentles</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Feng</surname><given-names>W</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Hoang</surname><given-names>CD</given-names></string-name>, <string-name><surname>Diehn</surname><given-names>M</given-names></string-name>, <string-name><surname>Alizadeh</surname><given-names>AA</given-names></string-name> (<year>2015</year>) <article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>. <source xml:lang="en">Nat Methods</source>
<volume>12</volume>: <fpage>453</fpage>–<lpage>457</lpage>
<pub-id pub-id-type="pmid">25822800</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0056">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0056"><string-name><surname>Newman</surname><given-names>AM</given-names></string-name>, <string-name><surname>Steen</surname><given-names>CB</given-names></string-name>, <string-name><surname>Liu</surname><given-names>CL</given-names></string-name>, <string-name><surname>Gentles</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Chaudhuri</surname><given-names>AA</given-names></string-name>, <string-name><surname>Scherer</surname><given-names>F</given-names></string-name>, <string-name><surname>Khodadoust</surname><given-names>MS</given-names></string-name>, <string-name><surname>Esfahani</surname><given-names>MS</given-names></string-name>, <string-name><surname>Luca</surname><given-names>BA</given-names></string-name>, <string-name><surname>Steiner</surname><given-names>D</given-names></string-name><italic>et al</italic> (<year>2019</year>) <article-title>Determining cell type abundance and expression from bulk tissues with digital cytometry</article-title>. <source xml:lang="en">Nat Biotechnol</source>
<volume>37</volume>: <fpage>773</fpage>–<lpage>782</lpage>
<pub-id pub-id-type="pmid">31061481</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0057">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0057"><string-name><surname>Obermoser</surname><given-names>G</given-names></string-name>, <string-name><surname>Presnell</surname><given-names>S</given-names></string-name>, <string-name><surname>Domico</surname><given-names>K</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Anguiano</surname><given-names>E</given-names></string-name>, <string-name><surname>Thompson‐Snipes</surname><given-names>L</given-names></string-name>, <string-name><surname>Ranganathan</surname><given-names>R</given-names></string-name>, <string-name><surname>Zeitner</surname><given-names>B</given-names></string-name>, <string-name><surname>Bjork</surname><given-names>A</given-names></string-name><italic>et al</italic> (<year>2013</year>) <article-title>Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines</article-title>. <source xml:lang="en">Immunity</source>
<volume>38</volume>: <fpage>831</fpage>–<lpage>844</lpage>
<pub-id pub-id-type="pmid">23601689</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0058">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0058"><string-name><surname>O'Connor</surname><given-names>D</given-names></string-name>, <string-name><surname>Clutterbuck</surname><given-names>EA</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Snape</surname><given-names>MD</given-names></string-name>, <string-name><surname>Ramasamy</surname><given-names>MN</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>DF</given-names></string-name>, <string-name><surname>Pollard</surname><given-names>AJ</given-names></string-name> (<year>2017</year>) <article-title>High‐dimensional assessment of B‐cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine</article-title>. <source xml:lang="en">Genome Med</source>
<volume>9</volume>: <fpage>11</fpage>
<pub-id pub-id-type="pmid">28137280</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0059">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0059"><string-name><surname>Parikh</surname><given-names>SR</given-names></string-name>, <string-name><surname>Andrews</surname><given-names>NJ</given-names></string-name>, <string-name><surname>Beebeejaun</surname><given-names>K</given-names></string-name>, <string-name><surname>Campbell</surname><given-names>H</given-names></string-name>, <string-name><surname>Ribeiro</surname><given-names>S</given-names></string-name>, <string-name><surname>Ward</surname><given-names>C</given-names></string-name>, <string-name><surname>White</surname><given-names>JM</given-names></string-name>, <string-name><surname>Borrow</surname><given-names>R</given-names></string-name>, <string-name><surname>Ramsay</surname><given-names>ME</given-names></string-name>, <string-name><surname>Ladhani</surname><given-names>SN</given-names></string-name> (<year>2016</year>) <article-title>Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study</article-title>. <source xml:lang="en">Lancet</source>
<volume>388</volume>: <fpage>2775</fpage>–<lpage>2782</lpage>
<pub-id pub-id-type="pmid">28100432</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0060">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0060"><string-name><surname>Pelham</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Pandya</surname><given-names>AN</given-names></string-name>, <string-name><surname>Agrawal</surname><given-names>DK</given-names></string-name> (<year>2014</year>) <article-title>Triggering receptor expressed on myeloid cells receptor family modulators: a patent review</article-title>. <source xml:lang="en">Expert Opin Ther Pat</source>
<volume>24</volume>: <fpage>1383</fpage>–<lpage>1395</lpage>
<pub-id pub-id-type="pmid">25363248</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0061">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0061"><string-name><surname>Pertea</surname><given-names>M</given-names></string-name>, <string-name><surname>Kim</surname><given-names>D</given-names></string-name>, <string-name><surname>Pertea</surname><given-names>GM</given-names></string-name>, <string-name><surname>Leek</surname><given-names>JT</given-names></string-name>, <string-name><surname>Salzberg</surname><given-names>SL</given-names></string-name> (<year>2016</year>) <article-title>Transcript‐level expression analysis of RNA‐seq experiments with HISAT, StringTie and Ballgown</article-title>. <source xml:lang="en">Nat Protoc</source>
<volume>11</volume>: <fpage>1650</fpage>–<lpage>1667</lpage>
<pub-id pub-id-type="pmid">27560171</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0062">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0062"><string-name><surname>Pollard</surname><given-names>AJ</given-names></string-name> (<year>2004</year>) <article-title>Global epidemiology of meningococcal disease and vaccine efficacy</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>
<volume>23</volume>: <fpage>S274</fpage>–<lpage>279</lpage>
<pub-id pub-id-type="pmid">15597069</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0063">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0063"><string-name><surname>Prymula</surname><given-names>R</given-names></string-name>, <string-name><surname>Siegrist</surname><given-names>C</given-names></string-name>, <string-name><surname>Chlibek</surname><given-names>R</given-names></string-name>, <string-name><surname>Zemlickova</surname><given-names>H</given-names></string-name>, <string-name><surname>Vackova</surname><given-names>M</given-names></string-name>, <string-name><surname>Smetana</surname><given-names>J</given-names></string-name>, <string-name><surname>Lommel</surname><given-names>P</given-names></string-name>, <string-name><surname>Kaliskova</surname><given-names>E</given-names></string-name>, <string-name><surname>Borys</surname><given-names>D</given-names></string-name>, <string-name><surname>Schuerman</surname><given-names>L</given-names></string-name> (<year>2009</year>) <article-title>Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open‐label, randomised controlled trials</article-title>. <source xml:lang="en">Lancet</source>
<volume>374</volume>: <fpage>1339</fpage>–<lpage>1350</lpage>
<pub-id pub-id-type="pmid">19837254</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0064">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0064"><string-name><surname>Prymula</surname><given-names>R</given-names></string-name>, <string-name><surname>Esposito</surname><given-names>S</given-names></string-name>, <string-name><surname>Zuccotti</surname><given-names>GV</given-names></string-name>, <string-name><surname>Xie</surname><given-names>F</given-names></string-name>, <string-name><surname>Toneatto</surname><given-names>D</given-names></string-name>, <string-name><surname>Kohl</surname><given-names>I</given-names></string-name>, <string-name><surname>Dull</surname><given-names>PM</given-names></string-name> (<year>2014</year>) <article-title>A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)</article-title>. <source xml:lang="en">Hum Vaccin Immunother</source>
<volume>10</volume>: <fpage>1993</fpage>–<lpage>2004</lpage>
<pub-id pub-id-type="pmid">25424809</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0065">
                <mixed-citation publication-type="book" id="msb20209888-cit-0065"><collab collab-type="authors">R Core Team</collab>
(<year>2013</year>) <source xml:lang="en">R: a language and environment for statistical computing</source>. <publisher-loc>Vienna</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0066">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0066"><string-name><surname>Read</surname><given-names>CB</given-names></string-name>, <string-name><surname>Kuijper</surname><given-names>JL</given-names></string-name>, <string-name><surname>Hjorth</surname><given-names>SA</given-names></string-name>, <string-name><surname>Heipel</surname><given-names>MD</given-names></string-name>, <string-name><surname>Tang</surname><given-names>X</given-names></string-name>, <string-name><surname>Fleetwood</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Dantzler</surname><given-names>JL</given-names></string-name>, <string-name><surname>Grell</surname><given-names>SN</given-names></string-name>, <string-name><surname>Kastrup</surname><given-names>J</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C</given-names></string-name><italic>et al</italic> (<year>2015</year>) <article-title>Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM‐1</article-title>. <source xml:lang="en">J Immunol</source>
<volume>194</volume>: <fpage>1417</fpage>–<lpage>1421</lpage>
<pub-id pub-id-type="pmid">25595774</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0067">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0067"><string-name><surname>Ritchie</surname><given-names>ME</given-names></string-name>, <string-name><surname>Phipson</surname><given-names>B</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Law</surname><given-names>CW</given-names></string-name>, <string-name><surname>Shi</surname><given-names>W</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name> (<year>2015</year>) <article-title>limma powers differential expression analyses for RNA‐sequencing and microarray studies</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<volume>43</volume>: <elocation-id>e47</elocation-id>
<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0068">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0068"><string-name><surname>Robinson</surname><given-names>MD</given-names></string-name>, <string-name><surname>McCarthy</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Smyth</surname><given-names>GK</given-names></string-name> (<year>2010</year>) <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source xml:lang="en">Bioinformatics</source>
<volume>26</volume>: <fpage>139</fpage>–<lpage>140</lpage>
<pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0069">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0069"><string-name><surname>Robinson</surname><given-names>MD</given-names></string-name>, <string-name><surname>Oshlack</surname><given-names>A</given-names></string-name> (<year>2010</year>) <article-title>A scaling normalization method for differential expression analysis of RNA‐seq data</article-title>. <source xml:lang="en">Genome Biol</source>
<volume>11</volume>: <fpage>R25</fpage>
<pub-id pub-id-type="pmid">20196867</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0070">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0070"><string-name><surname>Rollier</surname><given-names>CS</given-names></string-name>, <string-name><surname>Dold</surname><given-names>C</given-names></string-name>, <string-name><surname>Marsay</surname><given-names>L</given-names></string-name>, <string-name><surname>Sadarangani</surname><given-names>M</given-names></string-name>, <string-name><surname>Pollard</surname><given-names>AJ</given-names></string-name> (<year>2015</year>) <article-title>The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy</article-title>. <source xml:lang="en">Expert Opin Biol Ther</source>
<volume>15</volume>: <fpage>131</fpage>–<lpage>142</lpage>
<pub-id pub-id-type="pmid">25482879</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0071">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0071"><string-name><surname>Rouphael</surname><given-names>NG</given-names></string-name>, <string-name><surname>Stephens</surname><given-names>DS</given-names></string-name> (<year>2012</year>) <article-title><italic>Neisseria meningitidis</italic>: biology, microbiology, and epidemiology</article-title>. <source xml:lang="en">Methods Mol Biol</source>
<volume>799</volume>: <fpage>1</fpage>–<lpage>20</lpage>
<pub-id pub-id-type="pmid">21993636</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0072">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0072"><string-name><surname>Saleh</surname><given-names>E</given-names></string-name>, <string-name><surname>Moody</surname><given-names>MA</given-names></string-name>, <string-name><surname>Walter</surname><given-names>EB</given-names></string-name> (<year>2016</year>) <article-title>Effect of antipyretic analgesics on immune responses to vaccination</article-title>. <source xml:lang="en">Hum Vaccin Immunother</source>
<volume>12</volume>: <fpage>2391</fpage>–<lpage>2402</lpage>
<pub-id pub-id-type="pmid">27246296</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0073">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0073"><string-name><surname>Senn</surname><given-names>BM</given-names></string-name>, <string-name><surname>López‐Macías</surname><given-names>C</given-names></string-name>, <string-name><surname>Kalinke</surname><given-names>U</given-names></string-name>, <string-name><surname>Lamarre</surname><given-names>A</given-names></string-name>, <string-name><surname>Isibasi</surname><given-names>A</given-names></string-name>, <string-name><surname>Zinkernagel</surname><given-names>RM</given-names></string-name>, <string-name><surname>Hengartner</surname><given-names>H</given-names></string-name> (<year>2003</year>) <article-title>Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections</article-title>. <source xml:lang="en">Eur J Immunol</source>
<volume>33</volume>: <fpage>950</fpage>–<lpage>961</lpage>
<pub-id pub-id-type="pmid">12672061</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0074">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0074"><string-name><surname>Sheerin</surname><given-names>D</given-names></string-name>, <string-name><surname>O'Connor</surname><given-names>D</given-names></string-name>, <string-name><surname>Dold</surname><given-names>C</given-names></string-name>, <string-name><surname>Clutterbuck</surname><given-names>E</given-names></string-name>, <string-name><surname>Attar</surname><given-names>M</given-names></string-name>, <string-name><surname>Rollier</surname><given-names>CS</given-names></string-name>, <string-name><surname>Sadarangani</surname><given-names>M</given-names></string-name>, <string-name><surname>Pollard</surname><given-names>AJ</given-names></string-name> (<year>2019</year>) <article-title>Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane‐bound endotoxin of its outer membrane vesicle component</article-title>. <source xml:lang="en">Sci Rep</source>
<volume>9</volume>: <elocation-id>13797</elocation-id>
<pub-id pub-id-type="pmid">31551511</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0075">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0075"><string-name><surname>Smola</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Schölkopf</surname><given-names>B</given-names></string-name> (<year>2004</year>) <article-title>A tutorial on support vector regression</article-title>. <source xml:lang="en">Stat Comput</source>
<volume>14</volume>: <fpage>199</fpage>–<lpage>222</lpage>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0076">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0076"><string-name><surname>Snape</surname><given-names>MD</given-names></string-name>, <string-name><surname>Saroey</surname><given-names>P</given-names></string-name>, <string-name><surname>John</surname><given-names>TM</given-names></string-name>, <string-name><surname>Robinson</surname><given-names>H</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>S</given-names></string-name>, <string-name><surname>Gossger</surname><given-names>N</given-names></string-name>, <string-name><surname>Yu</surname><given-names>LM</given-names></string-name>, <string-name><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name><surname>Toneatto</surname><given-names>D</given-names></string-name>, <string-name><surname>Dull</surname><given-names>PM</given-names></string-name><italic>et al</italic> (<year>2013</year>) <article-title>Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose</article-title>. <source xml:lang="en">CMAJ</source>
<volume>185</volume>: <fpage>E715</fpage>–<lpage>E724</lpage>
<pub-id pub-id-type="pmid">24062178</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0077">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0077"><string-name><surname>Song</surname><given-names>MK</given-names></string-name>, <string-name><surname>Oh</surname><given-names>MS</given-names></string-name>, <string-name><surname>Lee</surname><given-names>JH</given-names></string-name>, <string-name><surname>Lee</surname><given-names>JN</given-names></string-name>, <string-name><surname>Chung</surname><given-names>JH</given-names></string-name>, <string-name><surname>Park</surname><given-names>SG</given-names></string-name>, <string-name><surname>Choi</surname><given-names>IH</given-names></string-name> (<year>2000</year>) <article-title>Light chain of natural antibody plays a dominant role in protein antigen binding</article-title>. <source xml:lang="en">Biochem Biophys Res Commun</source>
<volume>268</volume>: <fpage>390</fpage>–<lpage>394</lpage>
<pub-id pub-id-type="pmid">10679214</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0078">
                <mixed-citation publication-type="book" id="msb20209888-cit-0078"><string-name><surname>Song</surname><given-names>F</given-names></string-name>, <string-name><surname>Guo</surname><given-names>Z</given-names></string-name>, <string-name><surname>Mei</surname><given-names>D</given-names></string-name> (<year>2010</year>) <chapter-title>Feature selection using principal component analysis</chapter-title>
<source xml:lang="en">2010 International Conference on System Science, Engineering Design and Manufacturing Informatization</source>. pp. <fpage>27</fpage>–<lpage>30</lpage>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0079">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0079"><string-name><surname>Sørensen</surname><given-names>UB</given-names></string-name>, <string-name><surname>Henrichsen</surname><given-names>J</given-names></string-name>, <string-name><surname>Chen</surname><given-names>HC</given-names></string-name>, <string-name><surname>Szu</surname><given-names>SC</given-names></string-name> (<year>1990</year>) <article-title>Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods</article-title>. <source xml:lang="en">Microb Pathog</source>
<volume>8</volume>: <fpage>325</fpage>–<lpage>334</lpage>
<pub-id pub-id-type="pmid">2215183</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0080">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0080"><string-name><surname>Spielman</surname><given-names>RS</given-names></string-name>, <string-name><surname>Bastone</surname><given-names>LA</given-names></string-name>, <string-name><surname>Burdick</surname><given-names>JT</given-names></string-name>, <string-name><surname>Morley</surname><given-names>M</given-names></string-name>, <string-name><surname>Ewens</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Cheung</surname><given-names>VG</given-names></string-name> (<year>2007</year>) <article-title>Common genetic variants account for differences in gene expression among ethnic groups</article-title>. <source xml:lang="en">Nat Genet</source>
<volume>39</volume>: <fpage>226</fpage>–<lpage>231</lpage>
<pub-id pub-id-type="pmid">17206142</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0081">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0081"><string-name><surname>Stephens</surname><given-names>DS</given-names></string-name>, <string-name><surname>Greenwood</surname><given-names>B</given-names></string-name>, <string-name><surname>Brandtzaeg</surname><given-names>P</given-names></string-name> (<year>2007</year>) <article-title>Epidemic meningitis, meningococcaemia, and <italic>Neisseria meningitidis</italic>
</article-title>. <source xml:lang="en">Lancet</source>
<volume>369</volume>: <fpage>2196</fpage>–<lpage>2210</lpage>
<pub-id pub-id-type="pmid">17604802</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0082">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0082"><collab collab-type="authors">The Gene Ontology Consortium</collab>
(<year>2017</year>) <article-title>Expansion of the Gene Ontology knowledgebase and resources</article-title>. <source xml:lang="en">Nucleic Acids Res</source>
<volume>45</volume>: <fpage>D331</fpage>–<lpage>D338</lpage>
<pub-id pub-id-type="pmid">27899567</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0083">
                <mixed-citation publication-type="miscellaneous" id="msb20209888-cit-0083"><collab collab-type="authors">The Jackson Laboratory J</collab>
(<year>2007</year>) <article-title>Physiological Data Summary – C57BL/6J (000664)</article-title>.</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0084">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0084"><string-name><surname>Tomic</surname><given-names>A</given-names></string-name>, <string-name><surname>Tomic</surname><given-names>I</given-names></string-name>, <string-name><surname>Rosenberg‐Hasson</surname><given-names>Y</given-names></string-name>, <string-name><surname>Dekker</surname><given-names>CL</given-names></string-name>, <string-name><surname>Maecker</surname><given-names>HT</given-names></string-name>, <string-name><surname>Davis</surname><given-names>MM</given-names></string-name> (<year>2019</year>) <article-title>SIMON, an automated machine learning system reveals immune signatures of influenza vaccine responses</article-title>. <source xml:lang="en">bioRxiv</source>
<pub-id pub-id-type="doi">10.1101/545186</pub-id> [PREPRINT]</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0085">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0085"><string-name><surname>Tsang</surname><given-names>JS</given-names></string-name>, <string-name><surname>Schwartzberg</surname><given-names>PL</given-names></string-name>, <string-name><surname>Kotliarov</surname><given-names>Y</given-names></string-name>, <string-name><surname>Biancotto</surname><given-names>A</given-names></string-name>, <string-name><surname>Xie</surname><given-names>Z</given-names></string-name>, <string-name><surname>Germain</surname><given-names>RN</given-names></string-name>, <string-name><surname>Wang</surname><given-names>E</given-names></string-name>, <string-name><surname>Olnes</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Narayanan</surname><given-names>M</given-names></string-name>, <string-name><surname>Golding</surname><given-names>H</given-names></string-name><italic>et al</italic> (<year>2014</year>) <article-title>Global analyses of human immune variation reveal baseline predictors of postvaccination responses</article-title>. <source xml:lang="en">Cell</source>
<volume>157</volume>: <fpage>499</fpage>–<lpage>513</lpage>
<pub-id pub-id-type="pmid">24725414</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0086">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0086"><string-name><surname>Uehara</surname><given-names>A</given-names></string-name>, <string-name><surname>Sugawara</surname><given-names>Y</given-names></string-name>, <string-name><surname>Kurata</surname><given-names>S</given-names></string-name>, <string-name><surname>Fujimoto</surname><given-names>Y</given-names></string-name>, <string-name><surname>Fukase</surname><given-names>K</given-names></string-name>, <string-name><surname>Kusumoto</surname><given-names>S</given-names></string-name>, <string-name><surname>Satta</surname><given-names>Y</given-names></string-name>, <string-name><surname>Sasano</surname><given-names>T</given-names></string-name>, <string-name><surname>Sugawara</surname><given-names>S</given-names></string-name>, <string-name><surname>Takada</surname><given-names>H</given-names></string-name> (<year>2005</year>) <article-title>Chemically synthesized pathogen‐associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll‐like receptors, NOD1 and NOD2 in human oral epithelial cells</article-title>. <source xml:lang="en">Cell Microbiol</source>
<volume>7</volume>: <fpage>675</fpage>–<lpage>686</lpage>
<pub-id pub-id-type="pmid">15839897</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0087">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0087"><string-name><surname>Uematsu</surname><given-names>T</given-names></string-name>, <string-name><surname>Fujita</surname><given-names>T</given-names></string-name>, <string-name><surname>Nakaoka</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Hara</surname><given-names>T</given-names></string-name>, <string-name><surname>Kobayashi</surname><given-names>N</given-names></string-name>, <string-name><surname>Murakami</surname><given-names>Y</given-names></string-name>, <string-name><surname>Seiki</surname><given-names>M</given-names></string-name>, <string-name><surname>Sakamoto</surname><given-names>T</given-names></string-name> (<year>2016</year>) <article-title>Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus</article-title>. <source xml:lang="en">Sci Rep</source>
<volume>6</volume>: <elocation-id>37815</elocation-id>
<pub-id pub-id-type="pmid">27883071</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0088">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0088"><string-name><surname>Vallania</surname><given-names>F</given-names></string-name>, <string-name><surname>Tam</surname><given-names>A</given-names></string-name>, <string-name><surname>Lofgren</surname><given-names>S</given-names></string-name>, <string-name><surname>Schaffert</surname><given-names>S</given-names></string-name>, <string-name><surname>Azad</surname><given-names>TD</given-names></string-name>, <string-name><surname>Bongen</surname><given-names>E</given-names></string-name>, <string-name><surname>Haynes</surname><given-names>W</given-names></string-name>, <string-name><surname>Alsup</surname><given-names>M</given-names></string-name>, <string-name><surname>Alonso</surname><given-names>M</given-names></string-name>, <string-name><surname>Davis</surname><given-names>M</given-names></string-name><italic>et al</italic> (<year>2018</year>) <article-title>Leveraging heterogeneity across multiple datasets increases cell‐mixture deconvolution accuracy and reduces biological and technical biases</article-title>. <source xml:lang="en">Nat Commun</source>
<volume>9</volume>: <fpage>4735</fpage>
<pub-id pub-id-type="pmid">30413720</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0089">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0089"><string-name><surname>Van den Bruel</surname><given-names>A</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Haj‐Hassan</surname><given-names>T</given-names></string-name>, <string-name><surname>Stevens</surname><given-names>R</given-names></string-name>, <string-name><surname>Moll</surname><given-names>H</given-names></string-name>, <string-name><surname>Lakhanpaul</surname><given-names>M</given-names></string-name>, <string-name><surname>Mant</surname><given-names>D</given-names></string-name> (<year>2011</year>) <article-title>Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review</article-title>. <source xml:lang="en">BMJ</source>
<volume>342</volume>: <elocation-id>d3082</elocation-id>
<pub-id pub-id-type="pmid">21653621</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0090">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0090"><string-name><surname>van der Pol</surname><given-names>L</given-names></string-name>, <string-name><surname>Stork</surname><given-names>M</given-names></string-name>, <string-name><surname>van der Ley</surname><given-names>P</given-names></string-name> (<year>2015</year>) <article-title>Outer membrane vesicles as platform vaccine technology</article-title>. <source xml:lang="en">Biotechnol J</source>
<volume>10</volume>: <fpage>1689</fpage>–<lpage>1706</lpage>
<pub-id pub-id-type="pmid">26912077</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0091">
                <mixed-citation publication-type="book" id="msb20209888-cit-0091"><string-name><surname>Virgo</surname><given-names>P</given-names></string-name><article-title>Children's Reference Ranges for FBC</article-title>. <publisher-name>North Bristol NHS Trust</publisher-name>.</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0092">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0092"><string-name><surname>von Both</surname><given-names>U</given-names></string-name>, <string-name><surname>Berk</surname><given-names>M</given-names></string-name>, <string-name><surname>Agapow</surname><given-names>PM</given-names></string-name>, <string-name><surname>Wright</surname><given-names>JD</given-names></string-name>, <string-name><surname>Git</surname><given-names>A</given-names></string-name>, <string-name><surname>Hamilton</surname><given-names>MS</given-names></string-name>, <string-name><surname>Goldgof</surname><given-names>G</given-names></string-name>, <string-name><surname>Siddiqui</surname><given-names>N</given-names></string-name>, <string-name><surname>Bellos</surname><given-names>E</given-names></string-name>, <string-name><surname>Wright</surname><given-names>VJ</given-names></string-name><italic>et al</italic> (<year>2018</year>) <article-title><italic>Mycobacterium tuberculosis</italic> exploits a molecular off switch of the immune system for intracellular survival</article-title>. <source xml:lang="en">Sci Rep</source>
<volume>8</volume>: <fpage>661</fpage>
<pub-id pub-id-type="pmid">29330469</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0093">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0093"><string-name><surname>Vono</surname><given-names>M</given-names></string-name>, <string-name><surname>Lin</surname><given-names>A</given-names></string-name>, <string-name><surname>Norrby‐Teglund</surname><given-names>A</given-names></string-name>, <string-name><surname>Koup</surname><given-names>RA</given-names></string-name>, <string-name><surname>Liang</surname><given-names>F</given-names></string-name>, <string-name><surname>Loré</surname><given-names>K</given-names></string-name> (<year>2017</year>) <article-title>Neutrophils acquire the capacity for antigen presentation to memory CD4</article-title>. <source xml:lang="en">Blood</source>
<volume>129</volume>: <fpage>1991</fpage>–<lpage>2001</lpage>
<pub-id pub-id-type="pmid">28143882</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0094">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0094"><string-name><surname>Wang</surname><given-names>WC</given-names></string-name>, <string-name><surname>Goldman</surname><given-names>LM</given-names></string-name>, <string-name><surname>Schleider</surname><given-names>DM</given-names></string-name>, <string-name><surname>Appenheimer</surname><given-names>MM</given-names></string-name>, <string-name><surname>Subjeck</surname><given-names>JR</given-names></string-name>, <string-name><surname>Repasky</surname><given-names>EA</given-names></string-name>, <string-name><surname>Evans</surname><given-names>SS</given-names></string-name> (<year>1998</year>) <article-title>Fever‐range hyperthermia enhances L‐selectin‐dependent adhesion of lymphocytes to vascular endothelium</article-title>. <source xml:lang="en">J Immunol</source>
<volume>160</volume>: <fpage>961</fpage>–<lpage>969</lpage>
<pub-id pub-id-type="pmid">9551935</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0095">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0095"><string-name><surname>Wang</surname><given-names>B</given-names></string-name>, <string-name><surname>Zou</surname><given-names>H</given-names></string-name> (<year>2016</year>) <article-title>Sparse distance weighted discrimination</article-title>. <source xml:lang="en">J Comput Graph Stat</source>
<volume>25</volume>: <fpage>826</fpage>–<lpage>838</lpage>
</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0096">
                <mixed-citation publication-type="book" id="msb20209888-cit-0096"><string-name><surname>Weiner</surname><given-names>J</given-names></string-name> (<year>2016</year>) <source xml:lang="en">tmod: feature set enrichment analysis for metabolomics and transcriptomics</source>. <publisher-name>CRAN</publisher-name>, v.0.36</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0097">
                <mixed-citation publication-type="miscellaneous" id="msb20209888-cit-0097"><collab collab-type="authors">WHO</collab>
(<year>2018</year>) <article-title>World Health Organisation recommendations for routine immunization</article-title> Retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.who.int/immunization/policy/Immunization_routine_table1.pdf?ua=1">http://www.who.int/immunization/policy/Immunization_routine_table1.pdf?ua=1</ext-link> (accessed 4 November 2020).</mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0098">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0098"><string-name><surname>Wilder‐Smith</surname><given-names>A</given-names></string-name>, <string-name><surname>Memish</surname><given-names>Z</given-names></string-name> (<year>2003</year>) <article-title>Meningococcal disease and travel</article-title>. <source xml:lang="en">Int J Antimicrob Agents</source>
<volume>21</volume>: <fpage>102</fpage>–<lpage>106</lpage>
<pub-id pub-id-type="pmid">12615371</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0099">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0099"><string-name><surname>Wright</surname><given-names>VJ</given-names></string-name>, <string-name><surname>Herberg</surname><given-names>JA</given-names></string-name>, <string-name><surname>Kaforou</surname><given-names>M</given-names></string-name>, <string-name><surname>Shimizu</surname><given-names>C</given-names></string-name>, <string-name><surname>Eleftherohorinou</surname><given-names>H</given-names></string-name>, <string-name><surname>Shailes</surname><given-names>H</given-names></string-name>, <string-name><surname>Barendregt</surname><given-names>AM</given-names></string-name>, <string-name><surname>Menikou</surname><given-names>S</given-names></string-name>, <string-name><surname>Gormley</surname><given-names>S</given-names></string-name>, <string-name><surname>Berk</surname><given-names>M</given-names></string-name><italic>et al</italic> (<year>2018</year>) <article-title>Diagnosis of Kawasaki disease using a minimal whole‐blood gene expression signature</article-title>. <source xml:lang="en">JAMA Pediatr</source>
<volume>172</volume>: <elocation-id>e182293</elocation-id>
<pub-id pub-id-type="pmid">30083721</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0100">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0100"><string-name><surname>Xu</surname><given-names>JL</given-names></string-name>, <string-name><surname>Davis</surname><given-names>MM</given-names></string-name> (<year>2000</year>) <article-title>Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities</article-title>. <source xml:lang="en">Immunity</source>
<volume>13</volume>: <fpage>37</fpage>–<lpage>45</lpage>
<pub-id pub-id-type="pmid">10933393</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0101">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0101"><string-name><surname>Yamaguchi</surname><given-names>KD</given-names></string-name>, <string-name><surname>Ruderman</surname><given-names>DL</given-names></string-name>, <string-name><surname>Croze</surname><given-names>E</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>TC</given-names></string-name>, <string-name><surname>Velichko</surname><given-names>S</given-names></string-name>, <string-name><surname>Reder</surname><given-names>AT</given-names></string-name>, <string-name><surname>Salamon</surname><given-names>H</given-names></string-name> (<year>2008</year>) <article-title>IFN‐beta‐regulated genes show abnormal expression in therapy‐naïve relapsing‐remitting MS mononuclear cells: gene expression analysis employing all reported protein‐protein interactions</article-title>. <source xml:lang="en">J Neuroimmunol</source>
<volume>195</volume>: <fpage>116</fpage>–<lpage>120</lpage>
<pub-id pub-id-type="pmid">18279974</pub-id></mixed-citation>
              </ref>
              <ref id="msb20209888-bib-0102">
                <mixed-citation publication-type="journal" id="msb20209888-cit-0102"><string-name><surname>Zarbock</surname><given-names>A</given-names></string-name>, <string-name><surname>Ley</surname><given-names>K</given-names></string-name> (<year>2008</year>) <article-title>Mechanisms and consequences of neutrophil interaction with the endothelium</article-title>. <source xml:lang="en">Am J Pathol</source>
<volume>172</volume>: <fpage>1</fpage>–<lpage>7</lpage>
<pub-id pub-id-type="pmid">18079440</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
